Interleukin-7	B-protein
upregulates	O
the	O
interleukin-2-gene	B-DNA
expression	O
in	O
activated	B-cell_type
human	I-cell_type
T	I-cell_type
lymphocytes	I-cell_type
at	O
the	O
transcriptional	O
level	O
by	O
enhancing	O
the	O
DNA	O
binding	O
activities	O
of	O
both	O
nuclear	O
factor	O
of	O
activated	B-cell_type
T	I-cell_type
cells	I-cell_type
and	O
activator	B-protein
protein-1	I-protein
.	O

In	O
the	O
present	O
report	O
,	O
we	O
studied	O
the	O
role	O
of	O
the	O
stromal-derived	B-protein
cytokine	I-protein
interleukin-7	I-protein
(	O
IL-7	B-protein
)	O
in	O
the	O
IL-2-gene	B-DNA
regulation	O
in	O
activated	B-cell_type
T	I-cell_type
lymphocytes	I-cell_type
.	O

Production	O
of	O
IL-2	B-protein
requires	O
the	O
formation	O
of	O
transcription	B-protein
factors	I-protein
involved	O
in	O
the	O
IL-2-gene	B-DNA
regulation	O
.	O

T-cell	B-protein
receptor	I-protein
(	B-protein
TCR	I-protein
)	I-protein
/CD3	I-protein
engagement	O
results	O
in	O
the	O
activation	O
of	O
nuclear	O
factor	O
of	O
activated	B-cell_type
T	I-cell_type
cells	I-cell_type
(	O
NFAT	B-protein
)	O
,	O
activator	B-protein
protein-1	I-protein
(	O
AP-1	B-protein
)	O
,	O
and	O
nuclear	B-protein
factor	I-protein
kappaB	I-protein
(	O
NFkappaB	B-protein
)	O
,	O
whereas	O
the	O
CD28	B-protein
responsive	I-protein
complex	I-protein
(	O
CD28RC	B-protein
)	O
is	O
activated	O
in	O
response	O
to	O
the	O
CD28	B-protein
signal	O
.	O

Costimulation	O
of	O
phytohemagglutinin/anti-CD28	B-cell_line
activated	I-cell_line
T	I-cell_line
lymphocytes	I-cell_line
with	O
IL-7	B-protein
induces	O
a	O
fivefold	O
enhanced	O
IL-2	B-protein
-mRNA	O
accumulation	O
and	O
a	O
2.5-fold	O
enhanced	O
protein	O
secretion	O
.	O

The	O
IL-2-gene	B-DNA
transcription	O
rate	O
is	O
increased	O
3.4-fold	O
,	O
indicating	O
that	O
the	O
effect	O
of	O
IL-7	B-protein
is	O
in	O
part	O
mediated	O
at	O
the	O
transcriptional	O
level	O
.	O

The	O
molecular	O
mechanisms	O
underlying	O
the	O
IL-7	B-protein
effect	O
involve	O
the	O
upregulation	O
of	O
the	O
DNA	O
binding	O
activity	O
of	O
NFAT	B-protein
(	O
60	O
%	O
)	O
and	O
AP-1	B-protein
(	O
120	O
%	O
)	O
,	O
without	O
affecting	O
the	O
activities	O
of	O
NFkappaB	B-protein
and	O
CD28RC	B-protein
,	O
which	O
was	O
confirmed	O
by	O
transfection	O
assays	O
.	O

We	O
also	O
show	O
that	O
the	O
IL-7	B-protein
-induced	O
enhancement	O
of	O
the	O
AP-1	B-protein
-DNA	O
binding	O
activity	O
is	O
not	O
cyclosporin	O
A-sensitive	O
.	O

Since	O
AP-1	B-protein
is	O
part	O
of	O
the	O
NFAT	B-protein
complex	I-protein
,	O
we	O
conclude	O
that	O
the	O
IL-7	B-protein
-signaling	O
pathway	O
is	O
involved	O
in	O
the	O
activation	O
of	O
the	O
fos	B-protein
and	I-protein
jun	I-protein
proteins	I-protein
of	O
which	O
AP-1	B-protein
consists	O
.	O

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

Interleukin-7	NULL
Upregulates	NULL
the	NULL
Interleukin-2-Gene	NULL
Expression	NULL
in	NULL
Activated	NULL
Human	NULL
T	NULL
Lymphocytes	NULL
at	NULL
the	NULL
Transcriptional	NULL
Level	NULL
by	NULL
Enhancing	NULL
the	NULL
DNA	NULL
Binding	NULL
Activities	NULL
of	NULL
Both	NULL
Nuclear	NULL
Factor	NULL
of	NULL
Activated	NULL
T	NULL
Cells	NULL
and	NULL
Activator	NULL
Protein-1	NULL
By	NULL
Sonja	NULL
I.	NULL
Gringhuis	NULL
,	NULL
Lou	NULL
F.M.H	NULL
.	NULL

de	NULL
Leij	NULL
,	NULL
Emmy	NULL
W.	NULL
Verschuren	NULL
,	NULL
Peter	NULL
Borger	NULL
,	NULL
and	NULL
Edo	NULL
Vellenga	NULL
In	NULL
the	NULL
present	NULL
report	NULL
,	NULL
we	NULL
studied	NULL
the	NULL
role	NULL
of	NULL
the	NULL
stromal-derived	NULL
cytokine	NULL
interleukin-7	NULL
(	NULL
IL-7	NULL
)	NULL
in	NULL
the	NULL
IL-2-gene	NULL
regulation	NULL
in	NULL
activated	NULL
T	NULL
lymphocytes	NULL
.	NULL

Production	NULL
of	NULL
IL-2	NULL
requires	NULL
the	NULL
formation	NULL
of	NULL
transcription	NULL
factors	NULL
involved	NULL
in	NULL
the	NULL
IL-2-gene	NULL
regulation	NULL
.	NULL

T-cell	NULL
receptor	NULL
(	NULL
TCR	NULL
)	NULL
/CD3	NULL
engagement	NULL
results	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
(	NULL
NFAT	NULL
)	NULL
,	NULL
activator	NULL
protein-1	NULL
(	NULL
AP-1	NULL
)	NULL
,	NULL
and	NULL
nuclear	NULL
factor	NULL
«	NULL
B	NULL
(	NULL
NFB	NULL
)	NULL
,	NULL
whereas	NULL
the	NULL
CD28	NULL
responsive	NULL
complex	NULL
(	NULL
CD28RC	NULL
)	NULL
is	NULL
activated	NULL
in	NULL
response	NULL
to	NULL
the	NULL
CD28	NULL
signal	NULL
.	NULL

Costimulation	NULL
of	NULL
phytohemagglutinin/anti-CD28	NULL
activated	NULL
T	NULL
lymphocytes	NULL
with	NULL
IL-7	NULL
induces	NULL
a	NULL
fivefold	NULL
enhanced	NULL
IL-2-mRNA	NULL
accumulation	NULL
and	NULL
a	NULL
2.5-fold	NULL
enhanced	NULL
protein	NULL
secretion	NULL
.	NULL

The	NULL
IL-2	NULL
HE	NULL
EXPRESSION	NULL
OF	NULL
the	NULL
interleukin-2	NULL
(	NULL
IL-2	NULL
)	NULL
gene	NULL
is	NULL
primarily	NULL
regulated	NULL
at	NULL
the	NULL
transcriptional	NULL
level	NULL
.	NULL

The	NULL
transcription	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
is	NULL
controlled	NULL
by	NULL
a	NULL
300-base	NULL
pair	NULL
(	NULL
bp	NULL
)	NULL
region	NULL
in	NULL
front	NULL
of	NULL
the	NULL
transcription	NULL
initiation	NULL
site	NULL
.	NULL
``	NULL

Within	NULL
this	NULL
promoter	NULL
several	NULL
binding	NULL
sites	NULL
for	NULL
transcription	NULL
factors	NULL
have	NULL
been	NULL
identified	NULL
that	NULL
act	NULL
as	NULL
positive	NULL
regulatory	NULL
elements	NULL
.	NULL

Both	NULL
ubiquitous	NULL
and	NULL
T-cell	NULL
specific	NULL
proteins	NULL
have	NULL
been	NULL
implicated	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
IL-2-gene	NULL
transcription	NULL
(	NULL
reviewed	NULL
in	NULL
ref	NULL
.	NULL

2	NULL
)	NULL
.	NULL

The	NULL
promoter	NULL
includes	NULL
two	NULL
binding	NULL
sites	NULL
(	NULL
proximal	NULL
and	NULL
distal	NULL
)	NULL
for	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
(	NULL
NFAT	NULL
)	NULL
,	NULL
a	NULL
proximal-	NULL
and	NULL
distal-binding	NULL
site	NULL
for	NULL
activator	NULL
protein-1	NULL
(	NULL
AP-1	NULL
)	NULL
,	NULL
``	NULL
a	NULL
single-binding	NULL
site	NULL
for	NULL
NFB	NULL
,	NULL
``	NULL
a	NULL
binding	NULL
site	NULL
for	NULL
the	NULL
CsA	NULL
sensitive	NULL
Oct-1/0AP	NULL
``	NULL
``	NULL
complex	NULL
,	NULL
``	NULL
and	NULL
the	NULL
CD28	NULL
response	NULL
element	NULL
(	NULL
CD28RE	NULL
)	NULL
,	NULL
``	NULL
``	NULL
``	NULL
which	NULL
is	NULL
a	NULL
target	NULL
for	NULL
CD28RC	NULL
(	NULL
CD28	NULL
responsive	NULL
complex	NULL
)	NULL
and	NULL
for	NULL
other	NULL
transcription	NULL
factors	NULL
such	NULL
as	NULL
nuclear	NULL
factor	NULL
of	NULL
mitogen-activated	NULL
T	NULL
cells	NULL
(	NULL
NFE-MAT	NULL
)	NULL
and	NULL
TxRE-binding	NULL
factor	NULL
(	NULL
TxREF	NULL
)	NULL
that	NULL
are	NULL
not	NULL
necessarily	NULL
induced	NULL
by	NULL
the	NULL
CD28	NULL
signal	NULL
.	NULL
``	NULL

The	NULL
T-cell	NULL
specific	NULL
transcription	NULL
factor	NULL
NFAT	NULL
is	NULL
a	NULL
multi-protein	NULL
complex	NULL
consisting	NULL
of	NULL
NFAT	NULL
1	NULL
and	NULL
AP-1	NULL
.	NULL
``	NULL

The	NULL
phos-phoprotein	NULL
NFAT1	NULL
is	NULL
constitutively	NULL
present	NULL
in	NULL
the	NULL
cytoplasm	NULL
of	NULL
resting	NULL
T	NULL
cells	NULL
.	NULL

On	NULL
TCR	NULL
stimulation	NULL
,	NULL
NFAT1	NULL
becomes	NULL
dephosphorylated	NULL
directly	NULL
by	NULL
the	NULL
Ca**/calmodulin-depen-dent	NULL
phosphatase	NULL
calcineurin	NULL
and	NULL
translocates	NULL
into	NULL
the	NULL
nu-cleus	NULL
.	NULL

The	NULL
dephosphorylation	NULL
by	NULL
calcineurin	NULL
is	NULL
highly	NULL
sensitive	NULL
to	NULL
cyclosporin	NULL
A	NULL
.	NULL
``	NULL

''	NULL
In	NULL
the	NULL
nucleus	NULL
,	NULL
NFAT1	NULL
associates	NULL
with	NULL
AP-1	NULL
to	NULL
form	NULL
the	NULL
functional	NULL
transcription	NULL
factor	NULL
NFAT	NULL
,	NULL
which	NULL
will	NULL
then	NULL
bind	NULL
to	NULL
the	NULL
IL-2	NULL
promoter	NULL
.	NULL

AP-1	NULL
,	NULL
which	NULL
is	NULL
a	NULL
heterodimer	NULL
composed	NULL
of	NULL
fos	NULL
and	NULL
jun	NULL
family	NULL
members	NULL
,	NULL
can	NULL
From	NULL
the	NULL
Divisions	NULL
of	NULL
Hematology	NULL
,	NULL
Clinical	NULL
Immunology	NULL
,	NULL
and	NULL
Allergology	NULL
,	NULL
Department	NULL
of	NULL
Internal	NULL
Medicine	NULL
,	NULL
University	NULL
of	NULL
Groningen	NULL
,	NULL
Groningen	NULL
,	NULL
The	NULL
Netherlands	NULL
.	NULL

Address	NULL
reprint	NULL
request	NULL
to	NULL
Edo	NULL
Vellenga	NULL
,	NULL
MD	NULL
,	NULL
Division	NULL
of	NULL
Hematology	NULL
,	NULL
University	NULL
of	NULL
Groningen	NULL
,	NULL
Hanzeplein	NULL
1	NULL
,	NULL
9713	NULL
GZ	NULL
Groningen	NULL
,	NULL
The	NULL
Netherlands	NULL
.	NULL

The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

©	NULL
1997	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

0006-4971/97/9007-0029	NULL
$	NULL
3.00/0	NULL
2690	NULL
gene	NULL
transcription	NULL
rate	NULL
is	NULL
increased	NULL
3.4-fold	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
effect	NULL
of	NULL
IL-7	NULL
is	NULL
in	NULL
part	NULL
mediated	NULL
at	NULL
the	NULL
transcriptional	NULL
level	NULL
.	NULL

The	NULL
molecular	NULL
mechanisms	NULL
underlying	NULL
the	NULL
IL-7	NULL
effect	NULL
involve	NULL
the	NULL
upregulation	NULL
of	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
NFAT	NULL
(	NULL
60	NULL
%	NULL
)	NULL
and	NULL
AP-1	NULL
(	NULL
120	NULL
%	NULL
)	NULL
,	NULL
without	NULL
affecting	NULL
the	NULL
activities	NULL
of	NULL
NFB	NULL
and	NULL
CD28RC	NULL
,	NULL
which	NULL
was	NULL
confirmed	NULL
by	NULL
transfection	NULL
assays	NULL
.	NULL

We	NULL
also	NULL
show	NULL
that	NULL
the	NULL
IL-7-induced	NULL
enhancement	NULL
of	NULL
the	NULL
AP-1-DNA	NULL
binding	NULL
activity	NULL
is	NULL
not	NULL
cyclosporin	NULL
A-sensi-tive	NULL
.	NULL

Since	NULL
AP-1	NULL
is	NULL
part	NULL
of	NULL
the	NULL
NFAT	NULL
complex	NULL
,	NULL
we	NULL
conclude	NULL
that	NULL
the	NULL
IL-7-signaling	NULL
pathway	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
fos	NULL
and	NULL
jun	NULL
proteins	NULL
of	NULL
which	NULL
AP-1	NULL
consists	NULL
.	NULL

©	NULL
1997	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

also	NULL
bind	NULL
to	NULL
the	NULL
IL-2	NULL
promoter	NULL
on	NULL
its	NULL
own	NULL
.	NULL

The	NULL
AP-1	NULL
activity	NULL
is	NULL
regulated	NULL
both	NULL
at	NULL
the	NULL
level	NULL
of	NULL
fos	NULL
and	NULL
jun	NULL
gene	NULL
transcription	NULL
and	NULL
by	NULL
posttranslational	NULL
modifications	NULL
of	NULL
the	NULL
fos	NULL
and	NULL
jun	NULL
proteins	NULL
.	NULL
``	NULL

Recently	NULL
it	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
the	NULL
stromal-derived	NULL
cytokine	NULL
IL-7	NULL
plays	NULL
a	NULL
prominent	NULL
role	NULL
in	NULL
the	NULL
T-cell	NULL
development	NULL
in	NULL
the	NULL
thymus	NULL
.	NULL
``	NULL

In	NULL
addition	NULL
it	NULL
has	NULL
been	NULL
demonstrated	NULL
that	NULL
IL-7	NULL
enhances	NULL
the	NULL
expression	NULL
of	NULL
cytokine	NULL
genes	NULL
in	NULL
activated	NULL
T	NULL
and	NULL
natural	NULL
killer	NULL
(	NULL
NK	NULL
)	NULL
cells	NULL
.	NULL
``	NULL

IL-7	NULL
stimulates	NULL
cells	NULL
through	NULL
its	NULL
interaction	NULL
with	NULL
a	NULL
high-affinity	NULL
receptor	NULL
complex	NULL
composed	NULL
of	NULL
the	NULL
IL-7Ra	NULL
and	NULL
IL-2Ry	NULL
chains	NULL
.	NULL
``	NULL

The	NULL
increased	NULL
expression	NULL
of	NULL
Th1-cytokines	NULL
induced	NULL
by	NULL
IL-7	NULL
seems	NULL
in	NULL
part	NULL
to	NULL
be	NULL
regulated	NULL
at	NULL
the	NULL
transcriptional	NULL
level	NULL
.	NULL
``	NULL

''	NULL
However	NULL
,	NULL
limited	NULL
data	NULL
are	NULL
available	NULL
whether	NULL
IL-7	NULL
also	NULL
modulates	NULL
the	NULL
IL-2-gene	NULL
expression	NULL
,	NULL
at	NULL
which	NULL
level	NULL
IL-7	NULL
exerts	NULL
its	NULL
effects	NULL
,	NULL
and	NULL
what	NULL
signal	NULL
transduction	NULL
routes	NULL
are	NULL
involved	NULL
in	NULL
IL-7	NULL
signaling	NULL
.	NULL

Here	NULL
,	NULL
we	NULL
provide	NULL
the	NULL
first	NULL
evidence	NULL
that	NULL
IL-7	NULL
upregulates	NULL
the	NULL
IL-2	NULL
expression	NULL
in	NULL
activated	NULL
T	NULL
cells	NULL
through	NULL
a	NULL
significant	NULL
increase	NULL
of	NULL
the	NULL
IL-2-gene	NULL
transcription	NULL
rate	NULL
by	NULL
inducing	NULL
enhanced	NULL
DNA	NULL
binding	NULL
activities	NULL
of	NULL
transcription	NULL
factors	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
.	NULL

Both	NULL
AP-1	NULL
and	NULL
NFAT	NULL
,	NULL
which	NULL
also	NULL
contains	NULL
AP-1	NULL
,	NULL
show	NULL
increased	NULL
DNA	NULL
binding	NULL
on	NULL
costimulation	NULL
of	NULL
T	NULL
lymphocytes	NULL
with	NULL
IL-7	NULL
.	NULL

This	NULL
effect	NULL
was	NULL
specific	NULL
since	NULL
the	NULL
DNA	NULL
binding	NULL
activities	NULL
of	NULL
NFB	NULL
and	NULL
CD28RC	NULL
were	NULL
not	NULL
affected	NULL
by	NULL
IL-7	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
IL-7	NULL
acts	NULL
on	NULL
the	NULL
signaling	NULL
pathways	NULL
activating	NULL
the	NULL
AP-1	NULL
proteins	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
T-lymphocyte	NULL
isolation	NULL
.	NULL

-	NULL
Human	NULL
peripheral	NULL
blood	NULL
cells	NULL
were	NULL
obtained	NULL
from	NULL
healthy	NULL
volunteer	NULL
platelet	NULL
donors	NULL
,	NULL
and	NULL
mononuclear	NULL
cell	NULL
suspensions	NULL
were	NULL
prepared	NULL
by	NULL
Ficoll-Hypaque	NULL
(	NULL
Lymphoprep	NULL
;	NULL
Ny-comed	NULL
,	NULL
Oslo	NULL
,	NULL
Norway	NULL
)	NULL
density-gradient	NULL
centrifugation	NULL
.	NULL

T	NULL
lymphocytes	NULL
were	NULL
isolated	NULL
by	NULL
2-aminoethylisothiouronium	NULL
bromide-treated	NULL
sheep	NULL
red	NULL
blood	NULL
cell	NULL
(	NULL
SRBC	NULL
)	NULL
rosetting	NULL
.	NULL

The	NULL
SRBC	NULL
were	NULL
lysed	NULL
with	NULL
155	NULL
mmol/L	NULL
NH	NULL
,	NULL
CI1	NULL
,	NULL
10	NULL
mmol/L	NULL
KHCO	NULL
;	NULL
,	NULL
0.1	NULL
mmol/L	NULL
EDTA	NULL
,	NULL
according	NULL
to	NULL
standard	NULL
procedures	NULL
.	NULL

The	NULL
remaining	NULL
cell	NULL
preparations	NULL
contained	NULL
more	NULL
than	NULL
98	NULL
%	NULL
T	NULL
lymphocytes	NULL
as	NULL
assessed	NULL
by	NULL
flow	NULL
cytometric	NULL
analysis	NULL
after	NULL
staining	NULL
with	NULL
an	NULL
anti-CD2	NULL
monoclonal	NULL
antibody	NULL
(	NULL
MoAb	NULL
;	NULL
Becton	NULL
Dickinson	NULL
,	NULL
Mountain	NULL
View	NULL
,	NULL
CA	NULL
)	NULL
and	NULL
less	NULL
than	NULL
1	NULL
%	NULL
CD14*	NULL
cells	NULL
(	NULL
Becton	NULL
Dickinson	NULL
)	NULL
.	NULL

After	NULL
isolation	NULL
,	NULL
T	NULL
lymphocytes	NULL
were	NULL
kept	NULL
overnight	NULL
at	NULL
37°C	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
(	NULL
BioWhittaker	NULL
,	NULL
Blood	NULL
,	NULL
Vol	NULL
90	NULL
,	NULL
No	NULL
7	NULL
(	NULL
October	NULL
1	NULL
)	NULL
,	NULL
1997	NULL
:	NULL
pp	NULL
2690-2700	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

IL-2	NULL
GENE	NULL
REGULATION	NULL
BY	NULL
IL-7	NULL
IN	NULL
T	NULL
CELLS	NULL
Verviers	NULL
,	NULL
Belgium	NULL
)	NULL
containing	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
FCS	NULL
;	NULL
HyClone	NULL
,	NULL
Logan	NULL
,	NULL
UT	NULL
)	NULL
supplemented	NULL
with	NULL
2	NULL
mmol/L	NULL
L-glutamine	NULL
,	NULL
100	NULL
U/mL	NULL
penicillin	NULL
,	NULL
100	NULL
pg/mL	NULL
streptomycin	NULL
,	NULL
and	NULL
6	NULL
ng/mL	NULL
colistin	NULL
.	NULL

Cell	NULL
culture	NULL
.	NULL

The	NULL
human	NULL
leukemic	NULL
T-cell	NULL
line	NULL
Jurkat	NULL
was	NULL
cultured	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
containing	NULL
10	NULL
%	NULL
FCS	NULL
supplemented	NULL
with	NULL
2	NULL
mmol/L	NULL
L-glutamine	NULL
,	NULL
100	NULL
U/mL	NULL
penicillin	NULL
,	NULL
100	NULL
pg/mL	NULL
streptomycin	NULL
,	NULL
and	NULL
6	NULL
ng/mL	NULL
colistin	NULL
.	NULL

Stimulation	NULL
.	NULL

-	NULL
Human	NULL
T	NULL
lymphocytes	NULL
(	NULL
5	NULL
%	NULL
10	NULL
%	NULL
/mL	NULL
)	NULL
were	NULL
incubated	NULL
for	NULL
various	NULL
time	NULL
periods	NULL
with	NULL
2	NULL
ug/ml	NULL
phytohemagglutinin	NULL
(	NULL
PHA	NULL
;	NULL
Sigma	NULL
,	NULL
St	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
,	NULL
or	NULL
with	NULL
PHA	NULL
plus	NULL
a	NULL
MoAb	NULL
against	NULL
CD28	NULL
in	NULL
a	NULL
5	NULL
%	NULL
hybridoma	NULL
supernatant	NULL
solution	NULL
(	NULL
a	NULL
gift	NULL
from	NULL
Dr	NULL
R.	NULL
van	NULL
Lier	NULL
,	NULL
Central	NULL
Laboratory	NULL
of	NULL
the	NULL
Netherlands	NULL
Red	NULL
Cross	NULL
Blood	NULL
Transfusion	NULL
Service	NULL
,	NULL
Amsterdam	NULL
,	NULL
The	NULL
Netherlands	NULL
)	NULL
,	NULL
or	NULL
with	NULL
PHA	NULL
plus	NULL
anti-CD28	NULL
plus	NULL
recombinant	NULL
human	NULL
IL-7	NULL
(	NULL
a	NULL
gift	NULL
from	NULL
Dr	NULL
S.C.	NULL
Clark	NULL
,	NULL
Genetics	NULL
Institute	NULL
,	NULL
Cambridge	NULL
,	NULL
MA	NULL
)	NULL
used	NULL
at	NULL
a	NULL
dilution	NULL
of	NULL
1	NULL
:	NULL
©1,000	NULL
.	NULL
``	NULL

Anti-CD3	NULL
(	NULL
WT32	NULL
;	NULL
Division	NULL
of	NULL
Clinical	NULL
Immunology	NULL
,	NULL
University	NULL
of	NULL
Groningen	NULL
,	NULL
The	NULL
Netherlands	NULL
)	NULL
in	NULL
combination	NULL
with	NULL
anti-CD28	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
IL-7	NULL
,	NULL
was	NULL
also	NULL
used	NULL
as	NULL
a	NULL
5	NULL
%	NULL
hybridoma	NULL
supernatant	NULL
solution	NULL
.	NULL

Cyclosporin	NULL
A	NULL
(	NULL
CsA	NULL
)	NULL
was	NULL
added	NULL
30	NULL
minutes	NULL
before	NULL
stimulation	NULL
and	NULL
used	NULL
at	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
0.1	NULL
pg/mL	NULL
.	NULL

Measurement	NULL
of	NULL
IL-2	NULL
and	NULL
interferon-y	NULL
(	NULL
IFN-y	NULL
)	NULL
protein	NULL
.	NULL

-	NULL
Human	NULL
T	NULL
lymphocytes	NULL
(	NULL
1	NULL
%	NULL
10	NULL
%	NULL
/mL	NULL
)	NULL
were	NULL
stimulated	NULL
with	NULL
PHA	NULL
or	NULL
PHA	NULL
in	NULL
combination	NULL
with	NULL
anti-CD28	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
IL-7	NULL
for	NULL
12	NULL
and	NULL
24	NULL
hours	NULL
.	NULL

Costimulations	NULL
of	NULL
anti-CD3	NULL
with	NULL
anti-CD28	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
IL-7	NULL
for	NULL
12	NULL
and	NULL
24	NULL
hours	NULL
were	NULL
also	NULL
performed	NULL
.	NULL

Secreted	NULL
IL-2	NULL
protein	NULL
was	NULL
quantified	NULL
in	NULL
cell-free	NULL
supernatants	NULL
using	NULL
a	NULL
human	NULL
IL-2	NULL
enzyme-linked	NULL
immunosorbent	NULL
assay	NULL
(	NULL
ELISA	NULL
)	NULL
kit	NULL
(	NULL
R	NULL
&	NULL
D	NULL
Systems	NULL
,	NULL
Minneapolis	NULL
,	NULL
MN	NULL
)	NULL
as	NULL
recommended	NULL
by	NULL
the	NULL
manufacturer	NULL
.	NULL

Secreted	NULL
IFN-y	NULL
was	NULL
measured	NULL
using	NULL
a	NULL
human	NULL
IFN-y	NULL
ELISA	NULL
kit	NULL
(	NULL
Central	NULL
Laboratory	NULL
of	NULL
the	NULL
Netherlands	NULL
Red	NULL
Cross	NULL
Blood	NULL
Transfusion	NULL
Service	NULL
)	NULL
.	NULL

RNA	NULL
preparation	NULL
and	NULL
Northern	NULL
blot	NULL
analysis	NULL
.	NULL

Total	NULL
cellular	NULL
RNA	NULL
from	NULL
human	NULL
T	NULL
lymphocytes	NULL
stimulated	NULL
with	NULL
PHA	NULL
or	NULL
PHA	NULL
in	NULL
combination	NULL
with	NULL
anti-CD28	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
IL-7	NULL
for	NULL
3	NULL
and	NULL
6	NULL
hours	NULL
,	NULL
was	NULL
isolated	NULL
using	NULL
the	NULL
guanidium	NULL
isothiocyanate/	NULL
cesium	NULL
chloride	NULL
method	NULL
.	NULL
``	NULL

''	NULL
Fifteen	NULL
microgram	NULL
samples	NULL
of	NULL
total	NULL
cellular	NULL
RNA	NULL
were	NULL
size	NULL
fractionated	NULL
on	NULL
1.1	NULL
%	NULL
agarose	NULL
gels	NULL
with	NULL
2.2	NULL
mol/	NULL
L	NULL
formaldehyde	NULL
and	NULL
blotted	NULL
onto	NULL
nylon	NULL
membranes	NULL
(	NULL
Qiabrane	NULL
Nylon	NULL
Plus	NULL
;	NULL
QiaGen	NULL
,	NULL
Chatsworth	NULL
,	NULL
CA	NULL
)	NULL
.	NULL
``	NULL

cDNA	NULL
probes	NULL
were	NULL
labeled	NULL
with	NULL
[	NULL
a-P	NULL
]	NULL
dCTP	NULL
(	NULL
3,000	NULL
Ci/mmol	NULL
,	NULL
Amersham	NULL
,	NULL
Buckinghamshire	NULL
,	NULL
UK	NULL
)	NULL
by	NULL
the	NULL
random	NULL
hexamer-priming	NULL
method	NULL
.	NULL
``	NULL

''	NULL
The	NULL
following	NULL
cDNA	NULL
probes	NULL
were	NULL
used	NULL
:	NULL
(	NULL
1	NULL
)	NULL
the	NULL
0.8-kb	NULL
Pvull	NULL
insert	NULL
of	NULL
human	NULL
IL-2	NULL
cDNA	NULL
purified	NULL
from	NULL
the	NULL
pGEM-T	NULL
plasmid	NULL
(	NULL
a	NULL
gift	NULL
from	NULL
Dr	NULL
E.G.E	NULL
.	NULL

de	NULL
Vries	NULL
,	NULL
Division	NULL
of	NULL
Medical	NULL
Oncology	NULL
,	NULL
University	NULL
of	NULL
Groningen	NULL
,	NULL
The	NULL
Netherlands	NULL
)	NULL
,	NULL
(	NULL
2	NULL
)	NULL
the	NULL
0.6-kb	NULL
EcoRI/HindIII	NULL
insert	NULL
of	NULL
human	NULL
IFN-y	NULL
cDNA	NULL
purified	NULL
from	NULL
the	NULL
pSP65	NULL
plasmid	NULL
``	NULL
(	NULL
a	NULL
gift	NULL
from	NULL
Dr	NULL
C.B	NULL
.	NULL

Wilson	NULL
,	NULL
University	NULL
of	NULL
Washington	NULL
,	NULL
Seattle	NULL
,	NULL
WA	NULL
)	NULL
,	NULL
and	NULL
(	NULL
3	NULL
)	NULL
the	NULL
EcoR-linearized	NULL
pBR322	NULL
plasmid	NULL
containing	NULL
a	NULL
7.8-kb	NULL
human	NULL
288	NULL
cDNA	NULL
insert	NULL
.	NULL

Hybridization	NULL
was	NULL
performed	NULL
at	NULL
65°C	NULL
for	NULL
18	NULL
hours	NULL
in	NULL
0.5	NULL
mol/L	NULL
Na	NULL
,	NULL
HPO	NULL
,	NULL
[	NULL
pH	NULL
7.2	NULL
]	NULL
,	NULL
1	NULL
mmol/L	NULL
EDTA	NULL
,	NULL
7	NULL
%	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
(	NULL
SDS	NULL
)	NULL
.	NULL

Membranes	NULL
were	NULL
washed	NULL
once	NULL
in	NULL
2	NULL
%	NULL
sodium	NULL
saline	NULL
citrate	NULL
(	NULL
SSC	NULL
)	NULL
,	NULL
0.1	NULL
%	NULL
SDS	NULL
;	NULL
once	NULL
in	NULL
1	NULL
%	NULL
SSC	NULL
,	NULL
0.1	NULL
%	NULL
SDS	NULL
and	NULL
finally	NULL
in	NULL
0.3	NULL
%	NULL
SSC	NULL
,	NULL
0.1	NULL
%	NULL
SDS	NULL
for	NULL
30	NULL
minutes	NULL
at	NULL
65°C	NULL
.	NULL

mRNA	NULL
levels	NULL
were	NULL
quantified	NULL
using	NULL
a	NULL
PhosphorImaging	NULL
system	NULL
(	NULL
Molecular	NULL
Dynamics	NULL
,	NULL
Sun-nyvale	NULL
,	NULL
CA	NULL
)	NULL
and	NULL
the	NULL
ImageQuant	NULL
software	NULL
(	NULL
Molecular	NULL
Dynamics	NULL
)	NULL
.	NULL

mRNA	NULL
levels	NULL
were	NULL
normalized	NULL
with	NULL
respect	NULL
to	NULL
the	NULL
288	NULL
signal	NULL
.	NULL

Nuclear	NULL
run-on	NULL
transcription	NULL
assay	NULL
.	NULL

-	NULL
Nuclei	NULL
were	NULL
isolated	NULL
from	NULL
T	NULL
lymphocytes	NULL
stimulated	NULL
for	NULL
3	NULL
hours	NULL
with	NULL
PHA	NULL
plus	NULL
anti-CD28	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
IL-7	NULL
.	NULL

10°	NULL
T	NULL
lymphocytes	NULL
were	NULL
pelleted	NULL
at	NULL
500g	NULL
for	NULL
5	NULL
minutes	NULL
,	NULL
washed	NULL
twice	NULL
with	NULL
ice-cold	NULL
phosphate-buf-fered	NULL
saline	NULL
(	NULL
PBS	NULL
)	NULL
,	NULL
and	NULL
suspended	NULL
in	NULL
4	NULL
mL	NULL
of	NULL
lysis	NULL
buffer	NULL
(	NULL
10	NULL
mmol/	NULL
L	NULL
Tris-HCl	NULL
[	NULL
pH	NULL
7.5	NULL
]	NULL
,	NULL
3	NULL
mmol/L	NULL
MgC	NULL
]	NULL
;	NULL
,	NULL
10	NULL
mmol/L	NULL
NaCl	NULL
,	NULL
0.5	NULL
%	NULL
Nonidet	NULL
P-40	NULL
[	NULL
Boehringer	NULL
Mannheim	NULL
,	NULL
Mannheim	NULL
,	NULL
Germany	NULL
]	NULL
)	NULL
.	NULL

After	NULL
gentle	NULL
vortexing	NULL
,	NULL
the	NULL
suspension	NULL
was	NULL
incubated	NULL
on	NULL
ice	NULL
for	NULL
5	NULL
minutes	NULL
.	NULL

2691	NULL
Nuclei	NULL
were	NULL
pelleted	NULL
at	NULL
500g	NULL
for	NULL
5	NULL
minutes	NULL
and	NULL
resuspended	NULL
in	NULL
100	NULL
pL	NULL
.	NULL

glycerol	NULL
buffer	NULL
(	NULL
50	NULL
mmol/L	NULL
Tris-HCI	NULL
[	NULL
pH	NULL
8.0	NULL
]	NULL
,	NULL
40	NULL
%	NULL
glycerol	NULL
,	NULL
5	NULL
mmol/L	NULL
MgCl	NULL
,	NULL
,	NULL
0.1	NULL
mmol/L	NULL
EDTA	NULL
)	NULL
.	NULL

One	NULL
hundred	NULL
microliter	NULL
nuclei	NULL
suspension	NULL
was	NULL
added	NULL
to	NULL
80-zL	NULL
transcription	NULL
buffer	NULL
(	NULL
12.5	NULL
mmol/L	NULL
Tris-HCl	NULL
[	NULL
pH	NULL
8.0	NULL
]	NULL
,	NULL
6	NULL
mmol/L	NULL
MgC	NULL
,	NULL
125	NULL
mmol/L	NULL
KCI	NULL
,	NULL
2	NULL
mmol/L	NULL
DTT	NULL
,	NULL
1	NULL
mmol/L	NULL
ATP	NULL
,	NULL
1	NULL
mmol/L	NULL
CTP	NULL
,	NULL
1	NULL
mmol/L	NULL
GTP	NULL
,	NULL
40	NULL
U	NULL
RNAsin	NULL
(	NULL
Promega	NULL
Corp	NULL
,	NULL
Madison	NULL
,	NULL
WI	NULL
)	NULL
and	NULL
12.5	NULL
gL	NULL
[	NULL
&	NULL
-P	NULL
]	NULL
UTP	NULL
(	NULL
3,000	NULL
Ci/	NULL
mmol	NULL
,	NULL
Amersham	NULL
)	NULL
,	NULL
and	NULL
incubated	NULL
at	NULL
26°C	NULL
for	NULL
20	NULL
minutes	NULL
.	NULL

Transcription	NULL
was	NULL
terminated	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
200	NULL
gL	NULL
stop	NULL
buffer	NULL
(	NULL
10	NULL
mmol/	NULL
L	NULL
Tris-HCI	NULL
[	NULL
pH	NULL
7.41	NULL
,	NULL
500	NULL
mmol/L	NULL
NaCI	NULL
,	NULL
50	NULL
mmol/L	NULL
MgC	NULL
]	NULL
,	NULL
2	NULL
mmol/	NULL
L	NULL
CaC	NULL
]	NULL
;	NULL
)	NULL
plus	NULL
40	NULL
U	NULL
DNase	NULL
I	NULL
and	NULL
40	NULL
ug	NULL
yeast	NULL
tRNA	NULL
,	NULL
and	NULL
the	NULL
solution	NULL
was	NULL
incubated	NULL
at	NULL
37°C	NULL
for	NULL
20	NULL
minutes	NULL
.	NULL

After	NULL
proteinase	NULL
K	NULL
(	NULL
750	NULL
U/	NULL
mL	NULL
)	NULL
digestion	NULL
in	NULL
1	NULL
%	NULL
SDS	NULL
,	NULL
nuclear	NULL
RNA	NULL
was	NULL
isolated	NULL
by	NULL
phenol/	NULL
chloroform	NULL
extraction	NULL
and	NULL
two	NULL
ethanol-precipitations	NULL
.	NULL

RNA	NULL
was	NULL
further	NULL
purified	NULL
by	NULL
Sephadex	NULL
G-50	NULL
chromatography	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
)	NULL
according	NULL
to	NULL
the	NULL
instructions	NULL
of	NULL
the	NULL
manufacturer	NULL
.	NULL

Five	NULL
micrograms	NULL
of	NULL
the	NULL
following	NULL
ssDNAs	NULL
were	NULL
immobilized	NULL
on	NULL
nylon	NULL
membranes	NULL
(	NULL
Qiabrane	NULL
Nylon	NULL
Plus	NULL
;	NULL
QiaGen	NULL
)	NULL
:	NULL
(	NULL
1	NULL
)	NULL
Xba	NULL
I-linear-ized	NULL
pCAT3-enhancer	NULL
plasmid	NULL
(	NULL
Promega	NULL
;	NULL
negative	NULL
control	NULL
)	NULL
;	NULL
(	NULL
2	NULL
)	NULL
Aa-fI-linearized	NULL
pGEM-T	NULL
plasmid	NULL
containing	NULL
a	NULL
0.8-kb	NULL
human	NULL
IL-2	NULL
cDNA	NULL
fragment	NULL
and	NULL
(	NULL
3	NULL
)	NULL
EcoR-linearized	NULL
plasmid	NULL
containing	NULL
a	NULL
1.3-kb	NULL
rat	NULL
GAPDH	NULL
cDNA	NULL
fragment	NULL
.	NULL
``	NULL

Hybridization	NULL
of	NULL
labeled	NULL
RNA	NULL
to	NULL
these	NULL
membranes	NULL
was	NULL
performed	NULL
at	NULL
65°C	NULL
for	NULL
72	NULL
hours	NULL
in	NULL
0.5	NULL
mol/L	NULL
Na	NULL
,	NULL
HPO	NULL
,	NULL
[	NULL
pH	NULL
7.2	NULL
]	NULL
,	NULL
1	NULL
mmol/L	NULL
EDTA	NULL
,	NULL
7	NULL
%	NULL
SDS	NULL
.	NULL

Membranes	NULL
were	NULL
washed	NULL
once	NULL
in	NULL
2	NULL
%	NULL
SSC	NULL
,	NULL
0.1	NULL
%	NULL
SDS	NULL
,	NULL
once	NULL
in	NULL
2	NULL
%	NULL
SSC	NULL
,	NULL
once	NULL
in	NULL
2	NULL
%	NULL
SSC	NULL
with	NULL
1	NULL
pg/mL	NULL
RNase	NULL
A	NULL
and	NULL
finally	NULL
in	NULL
0.3	NULL
%	NULL
SSC	NULL
,	NULL
0.1	NULL
%	NULL
SDS	NULL
for	NULL
15	NULL
minutes	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

Quantification	NULL
of	NULL
transcription	NULL
rate	NULL
levels	NULL
was	NULL
performed	NULL
using	NULL
a	NULL
PhosphorImaging	NULL
system	NULL
and	NULL
the	NULL
ImageQuant	NULL
software	NULL
(	NULL
Molecular	NULL
Dynamics	NULL
)	NULL
.	NULL

Transcription	NULL
rates	NULL
were	NULL
normalized	NULL
with	NULL
respect	NULL
to	NULL
the	NULL
GAPDH	NULL
signal	NULL
.	NULL

Nuclear	NULL
extract	NULL
preparation	NULL
.	NULL

-	NULL
Nuclear	NULL
extracts	NULL
of	NULL
stimulated	NULL
T	NULL
lymphocytes	NULL
were	NULL
prepared	NULL
by	NULL
a	NULL
modification	NULL
of	NULL
the	NULL
method	NULL
described	NULL
by	NULL
J	NULL
.	NULL

Park	NULL
et	NULL
al	NULL
.	NULL
``	NULL

12	NULL
x	NULL
10	NULL
``	NULL
T	NULL
lymphocytes	NULL
were	NULL
stimulated	NULL
with	NULL
PHA	NULL
or	NULL
PHA	NULL
in	NULL
combination	NULL
with	NULL
anti-CD28	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
IL-7	NULL
for	NULL
2	NULL
or	NULL
4	NULL
hours	NULL
.	NULL

In	NULL
some	NULL
experiments	NULL
CsA	NULL
was	NULL
added	NULL
30	NULL
minutes	NULL
before	NULL
stimulation	NULL
.	NULL

Cells	NULL
were	NULL
obtained	NULL
by	NULL
centrifugation	NULL
at	NULL
500g	NULL
for	NULL
5	NULL
minutes	NULL
,	NULL
washed	NULL
once	NULL
with	NULL
PBS	NULL
,	NULL
and	NULL
resuspended	NULL
to	NULL
2.5	NULL
X	NULL
10°	NULL
cells/mL	NULL
in	NULL
buffer	NULL
A	NULL
(	NULL
10	NULL
mmol/L	NULL
HEPES	NULL
[	NULL
pH	NULL
7.9	NULL
]	NULL
,	NULL
10	NULL
mmol/L	NULL
KCI	NULL
,	NULL
0.1	NULL
mmol/L	NULL
EDTA	NULL
,	NULL
0.1	NULL
mmol/L	NULL
EGTA	NULL
,	NULL
1	NULL
mmol/L	NULL
DTT	NULL
)	NULL
supplemented	NULL
with	NULL
protease	NULL
inhibitors	NULL
(	NULL
5	NULL
pg/mL	NULL
leupeptin	NULL
[	NULL
Sigma	NULL
]	NULL
,	NULL
5	NULL
ug/mL	NULL
aprotinin	NULL
[	NULL
Sigma	NULL
]	NULL
,	NULL
1	NULL
mmol/L	NULL
phenyl-methylsulfonyl	NULL
fluoride	NULL
[	NULL
PMSF	NULL
;	NULL
Sigma	NULL
]	NULL
)	NULL
.	NULL

After	NULL
a	NULL
10-minute	NULL
incubation	NULL
on	NULL
ice	NULL
,	NULL
cells	NULL
were	NULL
lysed	NULL
by	NULL
adding	NULL
10	NULL
%	NULL
Nonidet	NULL
P-40	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
)	NULL
to	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
0.05	NULL
%	NULL
,	NULL
and	NULL
incubated	NULL
for	NULL
another	NULL
10	NULL
minutes	NULL
on	NULL
ice	NULL
.	NULL

The	NULL
cell	NULL
lysates	NULL
were	NULL
centrifuged	NULL
at	NULL
300g	NULL
for	NULL
10	NULL
minutes	NULL
by	NULL
4°C	NULL
.	NULL

The	NULL
nuclear	NULL
pellets	NULL
were	NULL
resuspended	NULL
in	NULL
buffer	NULL
C	NULL
,	NULL
a	NULL
high	NULL
salt	NULL
buffer	NULL
(	NULL
20	NULL
mmol/L	NULL
HEPES	NULL
[	NULL
pH	NULL
7.9	NULL
]	NULL
,	NULL
400	NULL
mmol/L	NULL
NaCl	NULL
,	NULL
1	NULL
mmol/L	NULL
EDTA	NULL
,	NULL
1	NULL
mmol/L	NULL
EGTA	NULL
,	NULL
1	NULL
mmol/L	NULL
DTT	NULL
)	NULL
``	NULL
supplemented	NULL
with	NULL
protease	NULL
inhibitors	NULL
(	NULL
5	NULL
pg/mL	NULL
leupeptin	NULL
,	NULL
5	NULL
ug/mL	NULL
aprotinin	NULL
,	NULL
1	NULL
mmol/L	NULL
PMSF	NULL
)	NULL
.	NULL

The	NULL
suspension	NULL
was	NULL
incubated	NULL
on	NULL
ice	NULL
for	NULL
30	NULL
minutes	NULL
with	NULL
occasional	NULL
shaking	NULL
to	NULL
extract	NULL
the	NULL
nuclear	NULL
proteins	NULL
and	NULL
finally	NULL
spun	NULL
down	NULL
in	NULL
a	NULL
microcentrifuge	NULL
for	NULL
5	NULL
minutes	NULL
.	NULL

The	NULL
supernatants	NULL
containing	NULL
the	NULL
extracted	NULL
nuclear	NULL
proteins	NULL
were	NULL
divided	NULL
in	NULL
small	NULL
aliquots	NULL
and	NULL
stored	NULL
at	NULL
-80°C	NULL
.	NULL

The	NULL
protein	NULL
concentration	NULL
of	NULL
the	NULL
nuclear	NULL
extracts	NULL
was	NULL
determined	NULL
by	NULL
the	NULL
Bradford	NULL
assay	NULL
.	NULL
``	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
.	NULL

-	NULL
The	NULL
sequences	NULL
of	NULL
the	NULL
synthetic	NULL
oligonucleotides	NULL
containing	NULL
the	NULL
binding	NULL
sequences	NULL
of	NULL
the	NULL
human	NULL
IL-2	NULL
promoter	NULL
,	NULL
used	NULL
in	NULL
the	NULL
gel	NULL
shift	NULL
assays	NULL
were	NULL
as	NULL
follows	NULL
:	NULL
NFAT	NULL
,	NULL
5'-GGAGGAAAAACTGTITTCATACAGAAGGCGT-3	NULL
'	NULL
-	NULL
(	NULL
corresponding	NULL
to	NULL
-286/-257	NULL
of	NULL
the	NULL
human	NULL
IL-2	NULL
promoter	NULL
)	NULL
;	NULL
AP-1	NULL
,	NULL
5-AAATTCCAA-AGAGTCATCAGA-3	NULL
'	NULL
(	NULL
-159/-139	NULL
)	NULL
;	NULL
NFB	NULL
,	NULL
5-AACAAAGAGGG-ATTITCACCTACAT-3	NULL
'	NULL
(	NULL
-212/-189	NULL
)	NULL
;	NULL
and	NULL
CD28RE	NULL
,	NULL
5	NULL
``	NULL
-gatcGTITA-AAGAAATTCCAAA-3	NULL
'	NULL
(	NULL
-167/-150	NULL
)	NULL
*	NULL
#	NULL
Fifty	NULL
nanograms	NULL
of	NULL
HPLC-purified	NULL
single-stranded	NULL
oligonucleotides	NULL
(	NULL
EuroGentec	NULL
,	NULL
Seraing	NULL
,	NULL
Belgium	NULL
)	NULL
were	NULL
end-labeled	NULL
with	NULL
T4	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

2692	NULL
polynucleotide	NULL
kinase	NULL
(	NULL
Promega	NULL
Corp	NULL
,	NULL
Madison	NULL
,	NULL
WI	NULL
)	NULL
and	NULL
[	NULL
y-P	NULL
]	NULL
ATP	NULL
(	NULL
3000	NULL
Ci/mmol	NULL
,	NULL
Amersham	NULL
)	NULL
,	NULL
separated	NULL
from	NULL
non-incorpo-rated	NULL
radiolabel	NULL
by	NULL
Sephadex	NULL
G50	NULL
chromatography	NULL
,	NULL
ethanol	NULL
precipi-tated	NULL
,	NULL
dried	NULL
and	NULL
dissolved	NULL
in	NULL
20	NULL
uL	NULL
annealing	NULL
buffer	NULL
(	NULL
10	NULL
mmol/L	NULL
Tris-HCl	NULL
[	NULL
pH	NULL
7.5	NULL
]	NULL
,	NULL
50	NULL
mmol/L	NULL
NaCl	NULL
,	NULL
10	NULL
mmol/L	NULL
MgC	NULL
]	NULL
;	NULL
,	NULL
1	NULL
mmol/	NULL
L	NULL
EDTA	NULL
,	NULL
1	NULL
mmol/L	NULL
DTT	NULL
)	NULL
with	NULL
a	NULL
fourfold	NULL
excess	NULL
of	NULL
the	NULL
opposite	NULL
strand	NULL
.	NULL

Annealing	NULL
of	NULL
the	NULL
two	NULL
strands	NULL
was	NULL
performed	NULL
by	NULL
heating	NULL
the	NULL
mixture	NULL
for	NULL
2	NULL
minutes	NULL
at	NULL
90°C	NULL
and	NULL
slow	NULL
cooling	NULL
to	NULL
room	NULL
temperature	NULL
.	NULL

Ten	NULL
micrograms	NULL
of	NULL
nuclear	NULL
extract	NULL
were	NULL
incubated	NULL
with	NULL
0.1	NULL
to	NULL
0.2	NULL
ng	NULL
double-stranded	NULL
labeled	NULL
oligonucleotide	NULL
in	NULL
15-zL	NULL
.	NULL

binding	NULL
buffer	NULL
(	NULL
20	NULL
mmol/L	NULL
HEPES	NULL
[	NULL
pH	NULL
7.9	NULL
]	NULL
,	NULL
60	NULL
mmol/L	NULL
KCI	NULL
,	NULL
0.06	NULL
mmol/L	NULL
EDTA	NULL
,	NULL
0.6	NULL
mmol/L	NULL
DTT	NULL
,	NULL
2	NULL
mmol/L	NULL
spermidine	NULL
,	NULL
10	NULL
%	NULL
glycerol	NULL
)	NULL
supplemented	NULL
with	NULL
2	NULL
ug	NULL
(	NULL
NFAT	NULL
,	NULL
AP-1	NULL
,	NULL
and	NULL
NFB	NULL
)	NULL
or	NULL
5	NULL
ug	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
(	NULL
CD28RE	NULL
)	NULL
.	NULL

The	NULL
binding	NULL
reaction	NULL
was	NULL
performed	NULL
for	NULL
20	NULL
minutes	NULL
at	NULL
26°C	NULL
.	NULL

In	NULL
competition	NULL
experiments	NULL
,	NULL
a	NULL
100-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
competitor	NULL
oligonucleotide	NULL
was	NULL
preincubated	NULL
with	NULL
the	NULL
nuclear	NULL
extract	NULL
for	NULL
10	NULL
minutes	NULL
on	NULL
ice	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
the	NULL
labeled	NULL
oligonucleotide	NULL
.	NULL

The	NULL
samples	NULL
were	NULL
loaded	NULL
onto	NULL
a	NULL
4	NULL
%	NULL
nondenaturing	NULL
polyacrylamide	NULL
gel	NULL
in	NULL
0.5	NULL
%	NULL
Tris-borate-EDTA	NULL
,	NULL
and	NULL
run	NULL
for	NULL
1	NULL
hour	NULL
at	NULL
140	NULL
V.	NULL
Quantification	NULL
of	NULL
binding	NULL
protein	NULL
was	NULL
performed	NULL
using	NULL
a	NULL
PhosphorImaging	NULL
system	NULL
and	NULL
the	NULL
ImageQuant	NULL
software	NULL
(	NULL
Molecular	NULL
Dynamics	NULL
)	NULL
.	NULL

Plasmids	NULL
.	NULL

-	NULL
The	NULL
Cla	NULL
VHindIH	NULL
fragment	NULL
of	NULL
the	NULL
p22.6CAT	NULL
plasmid	NULL
(	NULL
a	NULL
gift	NULL
from	NULL
Dr	NULL
C.L	NULL
.	NULL

Verweij	NULL
,	NULL
Department	NULL
of	NULL
Rheumatology	NULL
,	NULL
Academic	NULL
Hospital	NULL
Leiden	NULL
,	NULL
Leiden	NULL
,	NULL
The	NULL
Netherlands	NULL
)	NULL
containing	NULL
three	NULL
copies	NULL
of	NULL
the	NULL
distal	NULL
NFAT/IL-2	NULL
binding	NULL
site	NULL
(	NULL
GGAGGAAAAACT-GTTTCATACAGAAGGCGT	NULL
)	NULL
in	NULL
front	NULL
of	NULL
the	NULL
minimal	NULL
IL-2	NULL
promoter	NULL
,	NULL
``	NULL
was	NULL
subcloned	NULL
in	NULL
the	NULL
Sma	NULL
I	NULL
site	NULL
of	NULL
the	NULL
pCAT3-enhancer	NULL
reporter	NULL
plasmid	NULL
(	NULL
Promega	NULL
)	NULL
to	NULL
construct	NULL
the	NULL
reporter	NULL
plasmid	NULL
pCAT3e-3	NULL
X	NULL
NFAT/IL-2	NULL
.	NULL

The	NULL
reporter	NULL
plasmid	NULL
pX3-CAT	NULL
(	NULL
referred	NULL
to	NULL
as	NULL
pCAT-3	NULL
X	NULL
AP-1/IL-2	NULL
in	NULL
this	NULL
report	NULL
;	NULL
also	NULL
a	NULL
gift	NULL
from	NULL
Dr	NULL
C.L	NULL
.	NULL

Verweij	NULL
)	NULL
contains	NULL
3	NULL
copies	NULL
of	NULL
the	NULL
distal	NULL
AP-1	NULL
site	NULL
in	NULL
front	NULL
of	NULL
the	NULL
minimal	NULL
SV40	NULL
promoter	NULL
.	NULL

Both	NULL
the	NULL
empty	NULL
pCAT3-enhancer	NULL
plasmid	NULL
and	NULL
the	NULL
pCAT3-control	NULL
reporter	NULL
plasmid	NULL
(	NULL
Promega	NULL
)	NULL
served	NULL
as	NULL
controls	NULL
in	NULL
the	NULL
transfection	NULL
assays	NULL
.	NULL

Transfection	NULL
.	NULL

-	NULL
Resting	NULL
primary	NULL
T	NULL
cells	NULL
are	NULL
refractory	NULL
to	NULL
conventional	NULL
transfection	NULL
methods	NULL
.	NULL

Subsequently	NULL
it	NULL
was	NULL
necessary	NULL
to	NULL
use	NULL
a	NULL
prestimulation	NULL
method	NULL
.	NULL
``	NULL

''	NULL
Purified	NULL
human	NULL
T	NULL
lymphocytes	NULL
were	NULL
cultured	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
containing	NULL
10	NULL
%	NULL
FCS	NULL
,	NULL
2	NULL
mmol/L	NULL
L-glutamine	NULL
,	NULL
and	NULL
antibiotics	NULL
,	NULL
supplemented	NULL
with	NULL
PHA	NULL
at	NULL
1	NULL
pg/mL	NULL
,	NULL
and	NULL
recombinant	NULL
human	NULL
IL-2	NULL
(	NULL
Cetus	NULL
,	NULL
Emoryville	NULL
,	NULL
CA	NULL
)	NULL
at	NULL
100	NULL
U/mL	NULL
.	NULL

After	NULL
2	NULL
days	NULL
of	NULL
culture	NULL
,	NULL
the	NULL
nonadherent	NULL
cells	NULL
were	NULL
harvested	NULL
,	NULL
washed	NULL
once	NULL
with	NULL
PBS	NULL
,	NULL
and	NULL
resuspended	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
containing	NULL
10	NULL
%	NULL
FCS	NULL
,	NULL
2	NULL
mmol/L	NULL
L-glutamine	NULL
,	NULL
and	NULL
antibiotics	NULL
,	NULL
supplemented	NULL
with	NULL
only	NULL
recombinant	NULL
human	NULL
IL-2	NULL
at	NULL
100	NULL
U/mL	NULL
.	NULL

The	NULL
T	NULL
cells	NULL
were	NULL
incubated	NULL
for	NULL
2	NULL
more	NULL
days	NULL
,	NULL
washed	NULL
with	NULL
PBS	NULL
,	NULL
and	NULL
used	NULL
for	NULL
transient	NULL
transfection	NULL
assays	NULL
.	NULL

15	NULL
X	NULL
10°	NULL
T	NULL
lymphocytes	NULL
were	NULL
resuspended	NULL
in	NULL
400	NULL
gL	NULL
RPMI	NULL
1640	NULL
containing	NULL
10	NULL
%	NULL
FCS	NULL
,	NULL
2	NULL
mmol/L	NULL
L-glutamine	NULL
,	NULL
antibiotics	NULL
,	NULL
and	NULL
100	NULL
U/mL	NULL
IL-2	NULL
,	NULL
and	NULL
20	NULL
ug	NULL
(	NULL
1	NULL
ug/uL	NULL
.	NULL
)	NULL

reporter	NULL
plasmid	NULL
DNA	NULL
was	NULL
added	NULL
.	NULL

After	NULL
a	NULL
10-	NULL
minute	NULL
incubation	NULL
on	NULL
ice	NULL
,	NULL
cells	NULL
were	NULL
electroporated	NULL
using	NULL
a	NULL
BioRad	NULL
Gene	NULL
Pulser	NULL
(	NULL
BioRad	NULL
Laboratories	NULL
,	NULL
Richmond	NULL
,	NULL
CA	NULL
)	NULL
at	NULL
400	NULL
V	NULL
,	NULL
960	NULL
uF	NULL
.	NULL

After	NULL
an	NULL
additional	NULL
10	NULL
minute	NULL
incubation	NULL
period	NULL
on	NULL
ice	NULL
,	NULL
cells	NULL
were	NULL
transferred	NULL
to	NULL
RPMI	NULL
1640	NULL
containing	NULL
10	NULL
%	NULL
FCS	NULL
,	NULL
2	NULL
mmol/L	NULL
L-glutamine	NULL
,	NULL
antibiotics	NULL
,	NULL
and	NULL
100	NULL
U/	NULL
mL	NULL
IL-2	NULL
.	NULL

One	NULL
hour	NULL
after	NULL
electroporation	NULL
,	NULL
cells	NULL
were	NULL
divided	NULL
into	NULL
four	NULL
groups	NULL
and	NULL
left	NULL
unstimulated	NULL
or	NULL
stimulated	NULL
with	NULL
either	NULL
IL-7	NULL
alone	NULL
,	NULL
PHA	NULL
alone	NULL
or	NULL
PHA	NULL
plus	NULL
IL-7	NULL
.	NULL

After	NULL
24	NULL
hours	NULL
,	NULL
cells	NULL
were	NULL
harvested	NULL
and	NULL
resuspended	NULL
in	NULL
150	NULL
gL	NULL
250	NULL
mmol/L	NULL
Tris-HCl	NULL
[	NULL
pH	NULL
7.8	NULL
]	NULL
.	NULL

Total	NULL
cell	NULL
extracts	NULL
were	NULL
prepared	NULL
by	NULL
4	NULL
repeated	NULL
freeze/thaw	NULL
cycli	NULL
.	NULL

Transfection	NULL
of	NULL
Jurkat	NULL
cells	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
for	NULL
the	NULL
prestimulated	NULL
T	NULL
lymphocytes	NULL
,	NULL
except	NULL
that	NULL
no	NULL
IL-2	NULL
was	NULL
added	NULL
to	NULL
the	NULL
medium	NULL
and	NULL
the	NULL
electroporation	NULL
was	NULL
performed	NULL
at	NULL
300	NULL
V	NULL
,	NULL
960	NULL
uF	NULL
.	NULL

CAT	NULL
ELISA	NULL
.	NULL

-	NULL
CAT	NULL
concentrations	NULL
in	NULL
total	NULL
cell	NULL
extracts	NULL
were	NULL
measured	NULL
by	NULL
the	NULL
CAT	NULL
ELISA	NULL
kit	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
)	NULL
as	NULL
recom-	NULL
GRINGHUIS	NULL
ET	NULL
AL	NULL
mended	NULL
by	NULL
the	NULL
manufacturer	NULL
.	NULL

The	NULL
protein	NULL
concentration	NULL
of	NULL
the	NULL
cell	NULL
extracts	NULL
was	NULL
determined	NULL
by	NULL
the	NULL
Bradford	NULL
assay	NULL
,	NULL
``	NULL
and	NULL
results	NULL
from	NULL
the	NULL
CAT	NULL
ELISA	NULL
were	NULL
normalized	NULL
by	NULL
calculating	NULL
the	NULL
CAT	NULL
concentration	NULL
per	NULL
pg	NULL
protein	NULL
in	NULL
the	NULL
total	NULL
cell	NULL
extract	NULL
.	NULL

Statistical	NULL
analysis	NULL
.	NULL

-	NULL
Statistical	NULL
analyses	NULL
were	NULL
performed	NULL
on	NULL
the	NULL
secretion	NULL
and	NULL
transfection	NULL
data	NULL
using	NULL
the	NULL
Student	NULL
's	NULL
t-test	NULL
for	NULL
paired	NULL
observations	NULL
.	NULL

Statistical	NULL
significance	NULL
of	NULL
the	NULL
data	NULL
was	NULL
set	NULL
at	NULL
P	NULL
<	NULL
.05	NULL
.	NULL

RESULTS	NULL
IL-7	NULL
enhances	NULL
the	NULL
IL-2-protein	NULL
secretion	NULL
by	NULL
activated	NULL
T	NULL
lymphocytes	NULL
.	NULL

-	NULL
To	NULL
determine	NULL
whether	NULL
IL-7	NULL
has	NULL
an	NULL
effect	NULL
on	NULL
the	NULL
IL-2	NULL
secretion	NULL
by	NULL
activated	NULL
human	NULL
T	NULL
lymphocytes	NULL
,	NULL
purified	NULL
T	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
PHA	NULL
or	NULL
PHA	NULL
plus	NULL
anti-CD28	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
IL-7	NULL
.	NULL

Cell	NULL
free	NULL
supernatants	NULL
were	NULL
harvested	NULL
after	NULL
12	NULL
and	NULL
24	NULL
hours	NULL
.	NULL

As	NULL
depicted	NULL
in	NULL
Figure	NULL
1A	NULL
,	NULL
unstimulated	NULL
T	NULL
lymphocytes	NULL
secreted	NULL
only	NULL
very	NULL
low	NULL
levels	NULL
of	NULL
IL-2	NULL
protein	NULL
,	NULL
10	NULL
+	NULL
0.18	NULL
pg/mL	NULL
(	NULL
mean	NULL
+	NULL
SEM	NULL
;	NULL
n	NULL
=	NULL
4	NULL
)	NULL
.	NULL

T	NULL
lymphocytes	NULL
stimulated	NULL
with	NULL
PHA	NULL
alone	NULL
secreted	NULL
281	NULL
+	NULL
87	NULL
pg/mL	NULL
IL-2	NULL
(	NULL
mean	NULL
+	NULL
SEM	NULL
;	NULL
n	NULL
=	NULL
4	NULL
)	NULL
after	NULL
24	NULL
hours	NULL
of	NULL
stimulation	NULL
.	NULL

Costimulation	NULL
with	NULL
PHA	NULL
plus	NULL
IL-7	NULL
increased	NULL
the	NULL
IL-2	NULL
secretion	NULL
slightly	NULL
to	NULL
520	NULL
+	NULL
174	NULL
pg/mL	NULL
(	NULL
mean	NULL
+	NULL
SEM	NULL
;	NULL
n	NULL
=	NULL
4	NULL
;	NULL
P	NULL
=	NULL
.07	NULL
)	NULL
.	NULL

Stimulation	NULL
with	NULL
PHA	NULL
and	NULL
anti-CD28	NULL
resulted	NULL
in	NULL
a	NULL
significant	NULL
increase	NULL
of	NULL
the	NULL
IL-2	NULL
secretion	NULL
:	NULL
8,023	NULL
+	NULL
1,312	NULL
pg/mL	NULL
(	NULL
mean	NULL
+	NULL
SEM	NULL
;	NULL
n	NULL
=	NULL
4	NULL
;	NULL
P	NULL
=	NULL
.008	NULL
)	NULL
.	NULL

The	NULL
combined	NULL
treatment	NULL
of	NULL
PHA	NULL
plus	NULL
anti-CD28	NULL
plus	NULL
IL-7	NULL
resulted	NULL
in	NULL
an	NULL
almost	NULL
2.5-fold	NULL
increase	NULL
of	NULL
the	NULL
IL-2	NULL
secretion	NULL
to	NULL
19,955	NULL
+	NULL
2,497	NULL
pg/mL	NULL
(	NULL
mean	NULL
+	NULL
SEM	NULL
;	NULL
n	NULL
=	NULL
4	NULL
;	NULL
P	NULL
=	NULL
.004	NULL
)	NULL
.	NULL

The	NULL
observations	NULL
after	NULL
12	NULL
hours	NULL
of	NULL
stimulation	NULL
resembled	NULL
the	NULL
observations	NULL
after	NULL
24	NULL
hours	NULL
but	NULL
at	NULL
a	NULL
smaller	NULL
scale	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
amount	NULL
of	NULL
secreted	NULL
IFN-y	NULL
was	NULL
measured	NULL
in	NULL
the	NULL
supernatants	NULL
,	NULL
since	NULL
it	NULL
is	NULL
known	NULL
that	NULL
IL-7	NULL
upregulates	NULL
the	NULL
IFN-y	NULL
expression	NULL
in	NULL
anti-CD3/anti-CD28	NULL
stimulated	NULL
T	NULL
lymphocytes	NULL
.	NULL
``	NULL

Unstimulated	NULL
T	NULL
lymphocytes	NULL
did	NULL
not	NULL
secrete	NULL
any	NULL
detectable	NULL
IFN-y	NULL
(	NULL
Fig	NULL
1B	NULL
)	NULL
.	NULL

Stimulation	NULL
with	NULL
PHA	NULL
resulted	NULL
in	NULL
an	NULL
IFN-y	NULL
secretion	NULL
of	NULL
699	NULL
+	NULL
162	NULL
pg/mL	NULL
(	NULL
mean	NULL
+	NULL
SEM	NULL
;	NULL
n	NULL
=	NULL
4	NULL
)	NULL
after	NULL
24	NULL
hours	NULL
of	NULL
stimulation	NULL
.	NULL

IL-7	NULL
enhanced	NULL
the	NULL
secretion	NULL
of	NULL
IFN-y	NULL
to	NULL
a	NULL
level	NULL
of	NULL
1,441	NULL
+	NULL
210	NULL
pg/mL	NULL
(	NULL
mean	NULL
+	NULL
SEM	NULL
;	NULL
n	NULL
=	NULL
4	NULL
;	NULL
P	NULL
=	NULL
.011	NULL
)	NULL
.	NULL

T	NULL
lymphocytes	NULL
costimu-lated	NULL
with	NULL
PHA	NULL
and	NULL
anti-CD28	NULL
secreted	NULL
2,270	NULL
+	NULL
513	NULL
pg/mL	NULL
IFN-y	NULL
(	NULL
mean	NULL
+	NULL
SEM	NULL
;	NULL
n	NULL
=	NULL
4	NULL
;	NULL
P	NULL
=	NULL
.033	NULL
)	NULL
.	NULL

Costimulation	NULL
with	NULL
PHA	NULL
and	NULL
anti-CD28	NULL
plus	NULL
IL-7	NULL
resulted	NULL
in	NULL
an	NULL
approximately	NULL
twofold	NULL
increase	NULL
in	NULL
the	NULL
IFN-y	NULL
secretion	NULL
:	NULL
4,977	NULL
+	NULL
919	NULL
pg/	NULL
mL	NULL
(	NULL
mean	NULL
+	NULL
SEM	NULL
;	NULL
n	NULL
=	NULL
4	NULL
;	NULL
P	NULL
=	NULL
.024	NULL
)	NULL
.	NULL

IL-7	NULL
increases	NULL
the	NULL
IL-2	NULL
mRNA	NULL
accumulation	NULL
in	NULL
activated	NULL
T	NULL
lymphocytes	NULL
.	NULL

-	NULL
To	NULL
examine	NULL
whether	NULL
the	NULL
effects	NULL
of	NULL
IL-7	NULL
on	NULL
the	NULL
IL-2	NULL
mRNA	NULL
accumulation	NULL
in	NULL
activated	NULL
T	NULL
lymphocytes	NULL
corresponds	NULL
with	NULL
the	NULL
data	NULL
obtained	NULL
at	NULL
the	NULL
protein	NULL
level	NULL
,	NULL
total	NULL
RNA	NULL
was	NULL
isolated	NULL
from	NULL
cells	NULL
stimulated	NULL
for	NULL
3	NULL
or	NULL
6	NULL
hours	NULL
with	NULL
PHA	NULL
or	NULL
PHA	NULL
in	NULL
combination	NULL
with	NULL
anti-CD28	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
IL-7	NULL
.	NULL

After	NULL
3	NULL
hours	NULL
of	NULL
activation	NULL
hardly	NULL
any	NULL
IL-2	NULL
mRNA	NULL
could	NULL
be	NULL
detected	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
2A	NULL
,	NULL
after	NULL
6	NULL
hours	NULL
of	NULL
activation	NULL
a	NULL
faint	NULL
expression	NULL
of	NULL
IL-2	NULL
transcript	NULL
was	NULL
observed	NULL
in	NULL
T	NULL
lymphocytes	NULL
stimulated	NULL
with	NULL
either	NULL
PHA	NULL
alone	NULL
or	NULL
PHA	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-7	NULL
.	NULL

Costimulation	NULL
with	NULL
PHA	NULL
plus	NULL
anti-CD28	NULL
resulted	NULL
in	NULL
a	NULL
significant	NULL
accumulation	NULL
of	NULL
IL-2	NULL
mRNA	NULL
.	NULL

The	NULL
addition	NULL
of	NULL
IL-7	NULL
resulted	NULL
in	NULL
a	NULL
fivefold	NULL
enhanced	NULL
IL-2	NULL
mRNA	NULL
expression	NULL
(	NULL
n	NULL
=	NULL
4	NULL
;	NULL
Fig	NULL
2B	NULL
)	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

IL-2	NULL
GENE	NULL
REGULATION	NULL
BY	NULL
IL-7	NULL
IN	NULL
T	NULL
CELLS	NULL
2693	NULL
20000	NULL
(	NULL
--	NULL
20000	NULL
(	NULL
--	NULL
-	NULL
--	NULL
-A	NULL
C3	NULL
unstimulated	NULL
B	NULL
C	NULL
unstimulated	NULL
MPA	NULL
2	NULL
UPHA	NULL
-	NULL
14000	NULL
--	NULL
SPHAIL-7	NULL
&	NULL
18000	NULL
SPHA	NULL
,	NULL
IL-7	NULL
O.	NULL
g	NULL
MPHA	NULL
cCD28	NULL
7	NULL
BPHA	NULL
,	NULL
cCO28	NULL
S	NULL
APHA	NULL
,	NULL
aCO28	NULL
,	NULL
IL-7	NULL
o	NULL
PHA	NULL
,	NULL
aCD28	NULL
,	NULL
IL-7	NULL
5	NULL
1	NULL
%	NULL
,	NULL
10000	NULL
|-	NULL
§	NULL
10000	NULL
|	NULL
4	NULL
t.	NULL
)	NULL
U	NULL
G	NULL
to	NULL
|	NULL
E	NULL
(	NULL
Ti	NULL
G	NULL
=	NULL
s000	NULL
|-	NULL
ZU	NULL
‘	NULL
sooo	NULL
|	NULL
Y	NULL
IL	NULL
o	NULL
__	NULL
7	NULL
0	NULL
L	NULL
12	NULL
h	NULL
24h	NULL
24	NULL
h	NULL
Fig	NULL
1	NULL
.	NULL

IL-7	NULL
upregulates	NULL
the	NULL
IL-2	NULL
and	NULL
IFN-y	NULL
secretion	NULL
of	NULL
activated	NULL
human	NULL
T	NULL
lymphocytes	NULL
.	NULL

T	NULL
cells	NULL
were	NULL
left	NULL
unstimulated	NULL
or	NULL
stimulated	NULL
with	NULL
PHA	NULL
or	NULL
PHA	NULL
plus	NULL
anti-CD28	NULL
(	NULL
aCD28	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
IL-7	NULL
.	NULL

Cell	NULL
free	NULL
supernatants	NULL
were	NULL
harvested	NULL
after	NULL
12	NULL
and	NULL
24	NULL
hours	NULL
and	NULL
analyzed	NULL
for	NULL
secreted	NULL
(	NULL
A	NULL
)	NULL
IL-2	NULL
protein	NULL
and	NULL
(	NULL
B	NULL
)	NULL
IFN-y	NULL
protein	NULL
with	NULL
ELISAs	NULL
.	NULL

The	NULL
mean	NULL
values	NULL
for	NULL
the	NULL
IL-2	NULL
and	NULL
IFN-y	NULL
secretion	NULL
found	NULL
in	NULL
four	NULL
independent	NULL
experiments	NULL
are	NULL
shown	NULL
.	NULL

Rehybridization	NULL
with	NULL
an	NULL
IFN-y	NULL
cDNA	NULL
probe	NULL
showed	NULL
that	NULL
IFN-y	NULL
mRNA	NULL
accumulated	NULL
in	NULL
a	NULL
similar	NULL
fashion	NULL
as	NULL
IL-2	NULL
mRNA	NULL
,	NULL
but	NULL
in	NULL
a	NULL
much	NULL
smaller	NULL
degree	NULL
(	NULL
Fig	NULL
2A	NULL
)	NULL
.	NULL

IL-7	NULL
induced	NULL
an	NULL
almost	NULL
fold	NULL
increase	NULL
(	NULL
n	NULL
=	NULL
4	NULL
)	NULL
in	NULL
IFN-y	NULL
mRNA	NULL
accumulation	NULL
after	NULL
6	NULL
hours	NULL
of	NULL
stimulation	NULL
compared	NULL
with	NULL
the	NULL
combination	NULL
of	NULL
PHA	NULL
and	NULL
anti-CD28	NULL
alone	NULL
(	NULL
Fig	NULL
2B	NULL
)	NULL
.	NULL

IL-7	NULL
increases	NULL
the	NULL
IL-2-gene	NULL
transcription	NULL
rate	NULL
in	NULL
activated	NULL
T	NULL
lymphocytes	NULL
.	NULL

-	NULL
To	NULL
examine	NULL
whether	NULL
the	NULL
effect	NULL
of	NULL
the	NULL
IL-7	NULL
signal	NULL
on	NULL
the	NULL
IL-2	NULL
gene	NULL
expression	NULL
is	NULL
mediated	NULL
at	NULL
the	NULL
transcriptional	NULL
level	NULL
,	NULL
we	NULL
performed	NULL
a	NULL
nuclear	NULL
run-on	NULL
transcription	NULL
assay	NULL
to	NULL
measure	NULL
the	NULL
transcription	NULL
rate	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
.	NULL

Hardly	NULL
any	NULL
IL-2	NULL
mRNA	NULL
was	NULL
transcribed	NULL
in	NULL
T	NULL
lymphocytes	NULL
that	NULL
were	NULL
left	NULL
unstimulated	NULL
.	NULL

The	NULL
transcription	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
was	NULL
induced	NULL
by	NULL
stimulation	NULL
of	NULL
the	NULL
T	NULL
lymphocytes	NULL
with	NULL
PHA	NULL
and	NULL
anti-CD28	NULL
(	NULL
Fig	NULL
3A	NULL
)	NULL
.	NULL

The	NULL
addition	NULL
of	NULL
IL-7	NULL
upregulated	NULL
this	NULL
IL-2-transcription	NULL
rate	NULL
with	NULL
a	NULL
factor	NULL
3.4	NULL
(	NULL
n	NULL
=	NULL
4	NULL
;	NULL
Fig	NULL
3B	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
IL-7	NULL
regulates	NULL
the	NULL
IL-2-gene	NULL
expression	NULL
at	NULL
least	NULL
in	NULL
part	NULL
at	NULL
the	NULL
transcriptional	NULL
level	NULL
.	NULL

IL-7	NULL
enhances	NULL
the	NULL
binding	NULL
activities	NULL
of	NULL
NFAT	NULL
and	NULL
AP-1	NULL
to	NULL
the	NULL
IL-2	NULL
promoter	NULL
,	NULL
but	NULL
not	NULL
the	NULL
binding	NULL
activities	NULL
of	NULL
NFkB	NULL
or	NULL
CD28RC	NULL
.	NULL

_	NULL
To	NULL
study	NULL
the	NULL
molecular	NULL
basis	NULL
of	NULL
the	NULL
IL-7	NULL
induced	NULL
increase	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
transcription	NULL
rate	NULL
,	NULL
we	NULL
ana-lysed	NULL
the	NULL
binding	NULL
activities	NULL
of	NULL
NFAT	NULL
,	NULL
AP-1	NULL
,	NULL
NFB	NULL
,	NULL
and	NULL
CD28RC	NULL
to	NULL
their	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
human	NULL
IL-2	NULL
promoter	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
unstimulated	NULL
T	NULL
lymphocytes	NULL
or	NULL
T	NULL
lymphocytes	NULL
stimulated	NULL
for	NULL
2	NULL
hours	NULL
with	NULL
PHA	NULL
or	NULL
PHA	NULL
in	NULL
combination	NULL
with	NULL
anti-CD28	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
IL-7	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
4	NULL
,	NULL
no	NULL
NFAT	NULL
,	NULL
AP-1	NULL
,	NULL
NFxB	NULL
,	NULL
and	NULL
CD28RC	NULL
DNA	NULL
binding	NULL
activity	NULL
was	NULL
observed	NULL
in	NULL
unstimulated	NULL
T	NULL
lymphocytes	NULL
,	NULL
but	NULL
was	NULL
inducible	NULL
upon	NULL
stimulation	NULL
.	NULL

T	NULL
lymphocytes	NULL
stimulated	NULL
with	NULL
PHA	NULL
alone	NULL
showed	NULL
DNA	NULL
binding	NULL
activity	NULL
for	NULL
all	NULL
four	NULL
nuclear	NULL
factors	NULL
.	NULL

The	NULL
NFAT	NULL
,	NULL
AP-1	NULL
,	NULL
NFxB	NULL
,	NULL
and	NULL
CD28RC	NULL
complexes	NULL
bound	NULL
specifically	NULL
since	NULL
they	NULL
were	NULL
competed	NULL
for	NULL
by	NULL
a	NULL
100-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
double-stranded	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
same	NULL
respective	NULL
sites	NULL
,	NULL
and	NULL
not	NULL
by	NULL
negative	NULL
controls	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Costimulation	NULL
of	NULL
PHA	NULL
plus	NULL
IL-7	NULL
resulted	NULL
in	NULL
enhanced	NULL
DNA	NULL
binding	NULL
activities	NULL
for	NULL
NFAT	NULL
(	NULL
Fig	NULL
4A	NULL
)	NULL
and	NULL
AP-1	NULL
(	NULL
Fig	NULL
4B	NULL
)	NULL
.	NULL

The	NULL
NFAT	NULL
DNA	NULL
binding	NULL
acitivity	NULL
was	NULL
enhanced	NULL
by	NULL
60	NULL
+	NULL
9	NULL
%	NULL
(	NULL
mean	NULL
+	NULL
SEM	NULL
;	NULL
n	NULL
=	NULL
4	NULL
)	NULL
upon	NULL
costimulation	NULL
of	NULL
PHA	NULL
with	NULL
IL-7	NULL
compared	NULL
to	NULL
stimulation	NULL
with	NULL
PHA	NULL
alone	NULL
.	NULL

The	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
AP-1	NULL
increased	NULL
with	NULL
almost	NULL
120	NULL
+	NULL
2	NULL
%	NULL
(	NULL
mean	NULL
+	NULL
SEM	NULL
;	NULL
n	NULL
=	NULL
4	NULL
)	NULL
.	NULL

The	NULL
addition	NULL
of	NULL
IL-7	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
DNA	NULL
binding	NULL
activities	NULL
of	NULL
NFB	NULL
(	NULL
Fig	NULL
4C	NULL
)	NULL
and	NULL
CD28RC	NULL
(	NULL
Fig	NULL
4D	NULL
)	NULL
.	NULL

In	NULL
T	NULL
lymphocytes	NULL
stimulated	NULL
with	NULL
PHA	NULL
plus	NULL
anti-CD28	NULL
only	NULL
the	NULL
CD28RC	NULL
DNA	NULL
binding	NULL
was	NULL
enhanced	NULL
compared	NULL
with	NULL
T	NULL
lymphocytes	NULL
stimulated	NULL
with	NULL
PHA	NULL
alone	NULL
(	NULL
Fig	NULL
4D	NULL
)	NULL
.	NULL

Again	NULL
,	NULL
costimulation	NULL
with	NULL
IL-7	NULL
resulted	NULL
in	NULL
enhanced	NULL
NFAT	NULL
and	NULL
AP-1	NULL
DNA	NULL
binding	NULL
activities	NULL
(	NULL
Fig	NULL
4A	NULL
and	NULL
4B	NULL
)	NULL
,	NULL
whereas	NULL
no	NULL
effect	NULL
was	NULL
observed	NULL
on	NULL
the	NULL
NFB	NULL
and	NULL
CD28RC	NULL
DNA	NULL
binding	NULL
.	NULL

The	NULL
NFAT	NULL
DNA	NULL
binding	NULL
activity	NULL
was	NULL
increased	NULL
with	NULL
60	NULL
+	NULL
8	NULL
%	NULL
(	NULL
mean	NULL
+	NULL
SEM	NULL
;	NULL
n	NULL
=	NULL
4	NULL
)	NULL
,	NULL
and	NULL
the	NULL
AP-1	NULL
DNA	NULL
binding	NULL
was	NULL
increased	NULL
with	NULL
130	NULL
+	NULL
10	NULL
%	NULL
(	NULL
mean	NULL
+	NULL
SEM	NULL
;	NULL
n	NULL
=	NULL
4	NULL
)	NULL
.	NULL

Stimulation	NULL
of	NULL
4	NULL
h	NULL
with	NULL
IL-7	NULL
resulted	NULL
in	NULL
a	NULL
persisting	NULL
enhancement	NULL
in	NULL
NFAT	NULL
and	NULL
AP-1	NULL
DNA	NULL
binding	NULL
activities	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

IL-7	NULL
enhances	NULL
the	NULL
transcriptional	NULL
activities	NULL
of	NULL
both	NULL
NFAT	NULL
and	NULL
AP-1	NULL
.	NULL

To	NULL
examine	NULL
whether	NULL
the	NULL
IL-7	NULL
induced	NULL
enhanced	NULL
NFAT	NULL
and	NULL
AP-1	NULL
DNA	NULL
binding	NULL
activities	NULL
could	NULL
account	NULL
for	NULL
the	NULL
observed	NULL
enhanced	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
,	NULL
transient	NULL
transfection	NULL
experiments	NULL
were	NULL
performed	NULL
.	NULL

To	NULL
this	NULL
end	NULL
,	NULL
we	NULL
used	NULL
the	NULL
CAT	NULL
reporter	NULL
plasmids	NULL
pCAT3e-3	NULL
X	NULL
NFAT/IL-2	NULL
,	NULL
in	NULL
which	NULL
the	NULL
chloramphenicol	NULL
acetyl	NULL
transferase	NULL
gene	NULL
is	NULL
driven	NULL
by	NULL
three	NULL
copies	NULL
of	NULL
the	NULL
distal	NULL
NFAT	NULL
binding	NULL
site	NULL
of	NULL
the	NULL
human	NULL
IL-2	NULL
promoter	NULL
linked	NULL
to	NULL
the	NULL
minimal	NULL
IL-2	NULL
promoter	NULL
,	NULL
and	NULL
pCAT-3	NULL
X	NULL
AP-1/IL-2	NULL
,	NULL
in	NULL
which	NULL
the	NULL
CAT	NULL
gene	NULL
is	NULL
driven	NULL
by	NULL
three	NULL
copies	NULL
of	NULL
the	NULL
AP-1	NULL
site	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
linked	NULL
to	NULL
a	NULL
minimal	NULL
SV40	NULL
promoter	NULL
.	NULL

Since	NULL
resting	NULL
primary	NULL
T	NULL
lymphocytes	NULL
are	NULL
refractory	NULL
to	NULL
conventional	NULL
transfection	NULL
methods	NULL
,	NULL
it	NULL
was	NULL
necessary	NULL
to	NULL
use	NULL
a	NULL
prestimulation	NULL
method	NULL
as	NULL
described	NULL
by	NULL
J.-H.	NULL
Park	NULL
et	NULL
al	NULL
.	NULL
``	NULL

''	NULL
Purified	NULL
T	NULL
lymphocytes	NULL
were	NULL
first	NULL
cultured	NULL
with	NULL
PHA	NULL
plus	NULL
IL-2	NULL
for	NULL
48	NULL
hours	NULL
,	NULL
washed	NULL
,	NULL
and	NULL
incubated	NULL
for	NULL
another	NULL
48	NULL
hours	NULL
in	NULL
the	NULL
pres	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

2694	NULL
PHA	NULL
,	NULL
acD28	NULL
PHA	NULL
,	NULL
acCD28	NULL
,	NULL
IL-7	NULL
©	NULL
Av	NULL
-S	NULL
3	NULL
E	NULL
+	NULL
U	NULL
)	NULL
€	NULL
3	NULL
PHA	NULL
PHA	NULL
,	NULL
IL-7	NULL
IL-2	NULL
285	NULL
GRINGHUIS	NULL
ET	NULL
AL	NULL
IFN	NULL
gamma	NULL
60	NULL
B	NULL
g	NULL
C	NULL
unstimulated	NULL
[	NULL
a	NULL
)	NULL
L	NULL
~A	NULL
U	NULL
PHA	NULL
U	NULL
4	NULL
SPHA	NULL
,	NULL
IL-7	NULL
&	NULL
40	NULL
|-é	NULL
PHA	NULL
aCD28	NULL
<	NULL
PHA	NULL
,	NULL
acCD28	NULL
,	NULL
IL-7	NULL
Z	NULL
.	NULL

(	NULL
¥	NULL
E	NULL
.	NULL

w	NULL
20	NULL
|-	NULL
Fig	NULL
2	NULL
.	NULL

IL-7	NULL
upregulates	NULL
the	NULL
IL-2	NULL
and	NULL
IFN-y	NULL
mRNA	NULL
_	NULL
>	NULL
accumulation	NULL
in	NULL
activated	NULL
human	NULL
T	NULL
lymphocytes	NULL
.	NULL

T	NULL
‘	NULL
E	NULL
cells	NULL
were	NULL
left	NULL
unstimulated	NULL
or	NULL
stimulated	NULL
with	NULL
PHA	NULL
~0	NULL
|	NULL
.	NULL

or	NULL
PHA	NULL
plus	NULL
anti-CD28	NULL
(	NULL
aCD28	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
(	NULL
¥	NULL
.	NULL

absence	NULL
of	NULL
IL-7	NULL
.	NULL

Total	NULL
RNA	NULL
was	NULL
isolated	NULL
after	NULL
6	NULL
hours	NULL
of	NULL
stimulation	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Northern	NULL
hybridizations	NULL
with	NULL
IL-i	NULL
2	NULL
,	NULL
IFN-y	NULL
,	NULL
and	NULL
285	NULL
cDNA	NULL
probes	NULL
were	NULL
performed	NULL
.	NULL

(	NULL
B	NULL
)	NULL
O	NULL
mRNA	NULL
levels	NULL
were	NULL
quantified	NULL
using	NULL
a	NULL
PhosphorIm-IEN	NULL
gamma	NULL
aging	NULL
system	NULL
,	NULL
and	NULL
IL-2	NULL
and	NULL
IFN-y	NULL
mRNA	NULL
levels	NULL
were	NULL
ence	NULL
of	NULL
IL-2	NULL
alone	NULL
.	NULL

The	NULL
prestimulated	NULL
T	NULL
lymphocytes	NULL
were	NULL
then	NULL
transfected	NULL
with	NULL
either	NULL
pCAT3e-3	NULL
X	NULL
NFAT/IL-2	NULL
,	NULL
pCAT-3	NULL
%	NULL
AP-1/IL-2	NULL
,	NULL
or	NULL
the	NULL
empty	NULL
pCAT3-enhancer	NULL
plasmid	NULL
as	NULL
a	NULL
negative	NULL
control	NULL
.	NULL

No	NULL
CAT	NULL
protein	NULL
could	NULL
be	NULL
detected	NULL
in	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
empty	NULL
pCAT3-enhancer	NULL
plasmid	NULL
.	NULL

As	NULL
depicted	NULL
in	NULL
Fig	NULL
5	NULL
,	NULL
no	NULL
CAT	NULL
expression	NULL
was	NULL
detected	NULL
in	NULL
transfected	NULL
T	NULL
cells	NULL
stimulated	NULL
with	NULL
IL-7	NULL
alone	NULL
.	NULL

Stimulation	NULL
with	NULL
PHA	NULL
induced	NULL
CAT	NULL
expression	NULL
in	NULL
T	NULL
cells	NULL
that	NULL
were	NULL
transfected	NULL
with	NULL
either	NULL
pCAT3e-3	NULL
X	NULL
NFAT/IL-2	NULL
or	NULL
pCAT-3	NULL
X	NULL
AP-1/IL-2	NULL
.	NULL

The	NULL
CAT	NULL
expression	NULL
driven	NULL
by	NULL
the	NULL
three	NULL
NFAT	NULL
binding	NULL
sites	NULL
was	NULL
increased	NULL
by	NULL
44	NULL
+	NULL
7	NULL
%	NULL
(	NULL
mean	NULL
+	NULL
SEM	NULL
;	NULL
n	NULL
=	NULL
6	NULL
;	NULL
P	NULL
=	NULL
.002	NULL
)	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
IL-7	NULL
(	NULL
Fig	NULL
5A	NULL
)	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
when	NULL
Jurkat	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
pCAT3e-3	NULL
X	NULL
NFAT/IL-2	NULL
.	NULL

The	NULL
CAT	NULL
expression	NULL
normalized	NULL
with	NULL
respect	NULL
to	NULL
the	NULL
28S	NULL
signal	NULL
.	NULL

in	NULL
Jurkat	NULL
cells	NULL
was	NULL
increased	NULL
by	NULL
32	NULL
+	NULL
5	NULL
%	NULL
(	NULL
mean	NULL
+	NULL
SEM	NULL
;	NULL
n	NULL
=	NULL
3	NULL
;	NULL
P	NULL
=	NULL
.021	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-7	NULL
compared	NULL
with	NULL
stimulation	NULL
with	NULL
PHA	NULL
alone	NULL
(	NULL
Fig	NULL
5A	NULL
)	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
costimulation	NULL
with	NULL
IL-7	NULL
on	NULL
the	NULL
AP-1	NULL
driven	NULL
CAT	NULL
expression	NULL
in	NULL
transfected	NULL
T	NULL
cells	NULL
was	NULL
even	NULL
more	NULL
pronounced	NULL
:	NULL
the	NULL
CAT	NULL
expression	NULL
was	NULL
increased	NULL
with	NULL
79	NULL
+	NULL
4	NULL
%	NULL
(	NULL
mean	NULL
+	NULL
SEM	NULL
;	NULL
n	NULL
=	NULL
3	NULL
;	NULL
P	NULL
=	NULL
.002	NULL
;	NULL
Fig	NULL
5B	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
addition	NULL
of	NULL
IL-7	NULL
resulted	NULL
in	NULL
enhanced	NULL
transcriptional	NULL
activities	NULL
of	NULL
NFAT	NULL
and	NULL
AP-1	NULL
.	NULL

Together	NULL
with	NULL
the	NULL
results	NULL
of	NULL
the	NULL
EMSA	NULL
experiments	NULL
which	NULL
showed	NULL
that	NULL
the	NULL
NFAT	NULL
and	NULL
AP-1	NULL
DNA	NULL
binding	NULL
activities	NULL
were	NULL
enhanced	NULL
by	NULL
IL-7	NULL
(	NULL
Fig	NULL
4A	NULL
and	NULL
4B	NULL
)	NULL
,	NULL
these	NULL
results	NULL
suggest	NULL
that	NULL
IL-7	NULL
increases	NULL
the	NULL
IL-2	NULL
transcription	NULL
(	NULL
Fig	NULL
2A	NULL
)	NULL
by	NULL
enhancing	NULL
the	NULL
DNA	NULL
binding	NULL
and	NULL
transcriptional	NULL
activities	NULL
of	NULL
AP-1	NULL
and	NULL
NFAT	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

IL-2	NULL
GENE	NULL
REGULATION	NULL
BY	NULL
IL-7	NULL
IN	NULL
T	NULL
CELLS	NULL
A	NULL
control	NULL
IL-2	NULL
GAPDH	NULL
O	NULL
4	NULL
0	NULL
ad	NULL
6	NULL
A	NULL
3	NULL
€	NULL
o	NULL
!	NULL

Tn	NULL
.	NULL

:	NULL
§	NULL
QL	NULL
PHA	NULL
,	NULL
acCD28	NULL
,	NULL
IL-7	NULL
O	NULL
unstimulated	NULL
EPA	NULL
,	NULL
ccCD28	NULL
*	NULL
‘	NULL
SPHA	NULL
aCD28	NULL
,	NULL
L-7	NULL
Relative	NULL
IL-2	NULL
transcription	NULL
rate	NULL
N	NULL
Fig	NULL
3	NULL
.	NULL

IL-7	NULL
increases	NULL
the	NULL
IL-2-gene	NULL
transcription	NULL
rate	NULL
in	NULL
activated	NULL
human	NULL
T	NULL
lymphocytes	NULL
.	NULL

Nuclei	NULL
were	NULL
isolated	NULL
from	NULL
unstimulated	NULL
T	NULL
cells	NULL
or	NULL
T	NULL
cells	NULL
stimulated	NULL
for	NULL
3	NULL
hours	NULL
with	NULL
PHA	NULL
plus	NULL
anti-CD28	NULL
(	NULL
aCD28	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
IL-7	NULL
,	NULL
and	NULL
the	NULL
transcription	NULL
was	NULL
allowed	NULL
to	NULL
proceed	NULL
for	NULL
another	NULL
20	NULL
minutes	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
P-labeled	NULL
UTP	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Nuclear	NULL
RNA	NULL
was	NULL
isolated	NULL
and	NULL
hybridized	NULL
to	NULL
a	NULL
membrane	NULL
containing	NULL
linearized	NULL
cDNAs	NULL
for	NULL
IL-2	NULL
and	NULL
GAPDH	NULL
.	NULL

The	NULL
pCAT3-enhancer	NULL
plasmid	NULL
was	NULL
included	NULL
as	NULL
a	NULL
negative	NULL
control	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Transcription	NULL
rates	NULL
were	NULL
quantified	NULL
using	NULL
a	NULL
PhosphorImaging	NULL
system	NULL
,	NULL
and	NULL
IL-2	NULL
transcription	NULL
rates	NULL
were	NULL
normalized	NULL
with	NULL
respect	NULL
to	NULL
the	NULL
GAPDH	NULL
signal	NULL
,	NULL
as	NULL
described	NULL
in	NULL
the	NULL
Materials	NULL
and	NULL
Methods	NULL
section	NULL
.	NULL

The	NULL
results	NULL
are	NULL
expressed	NULL
as	NULL
relative	NULL
transcription	NULL
rate	NULL
compared	NULL
to	NULL
the	NULL
PHA/anti-CD28-induced	NULL
IL-2	NULL
transcription	NULL
rate	NULL
,	NULL
which	NULL
was	NULL
set	NULL
at	NULL
1	NULL
.	NULL

Cyclosporin	NULL
A	NULL
(	NULL
CsA	NULL
)	NULL
has	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
increased	NULL
binding	NULL
of	NULL
AP-1	NULL
induced	NULL
by	NULL
IL-7	NULL
,	NULL
while	NULL
partly	NULL
inhibiting	NULL
the	NULL
NFAT	NULL
binding	NULL
.	NULL

CsA	NULL
is	NULL
an	NULL
immuno-suppressive	NULL
drug	NULL
that	NULL
acts	NULL
by	NULL
inhibiting	NULL
the	NULL
phosphatase	NULL
activity	NULL
of	NULL
calcineurin	NULL
.	NULL

The	NULL
cytoplasmic	NULL
component	NULL
of	NULL
NFAT	NULL
,	NULL
NFAT1	NULL
needs	NULL
to	NULL
be	NULL
dephosphorylated	NULL
by	NULL
calcineurin	NULL
before	NULL
it	NULL
can	NULL
translocate	NULL
2695	NULL
into	NULL
the	NULL
nucleus	NULL
,	NULL
and	NULL
form	NULL
a	NULL
DNA-binding	NULL
complex	NULL
with	NULL
AP-1	NULL
.	NULL

Subsequently	NULL
,	NULL
CsA	NULL
treatment	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
will	NULL
partly	NULL
inhibit	NULL
the	NULL
IL-2	NULL
expression	NULL
.	NULL
``	NULL

''	NULL
Since	NULL
IL-7	NULL
enhances	NULL
both	NULL
the	NULL
AP-1	NULL
and	NULL
NFAT	NULL
DNA	NULL
binding	NULL
to	NULL
the	NULL
IL-2	NULL
promoter	NULL
,	NULL
we	NULL
were	NULL
interested	NULL
whether	NULL
CsA	NULL
could	NULL
block	NULL
these	NULL
IL-7-induced	NULL
enhancements	NULL
.	NULL

To	NULL
address	NULL
this	NULL
question	NULL
,	NULL
nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
T	NULL
lymphocytes	NULL
stimulated	NULL
for	NULL
2	NULL
hours	NULL
with	NULL
PHA	NULL
plus	NULL
anti-CD28	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
IL-7	NULL
,	NULL
with	NULL
or	NULL
without	NULL
the	NULL
addition	NULL
of	NULL
CsA	NULL
.	NULL

The	NULL
nuclear	NULL
extracts	NULL
were	NULL
analyzed	NULL
for	NULL
DNA	NULL
binding	NULL
factors	NULL
by	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
(	NULL
EMSA	NULL
)	NULL
.	NULL

At	NULL
the	NULL
same	NULL
time	NULL
,	NULL
T	NULL
lymphocytes	NULL
were	NULL
stimulated	NULL
for	NULL
24	NULL
hours	NULL
,	NULL
and	NULL
the	NULL
supernatants	NULL
were	NULL
analyzed	NULL
for	NULL
secreted	NULL
IL-2	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
6A	NULL
,	NULL
the	NULL
PHA/anti-CD28	NULL
induced	NULL
DNA	NULL
binding	NULL
of	NULL
NFAT	NULL
and	NULL
AP-1	NULL
was	NULL
again	NULL
increased	NULL
with	NULL
,	NULL
respectively	NULL
,	NULL
70	NULL
+	NULL
11	NULL
%	NULL
(	NULL
mean	NULL
+	NULL
SEM	NULL
;	NULL
n	NULL
=	NULL
4	NULL
)	NULL
and	NULL
110	NULL
+	NULL
9	NULL
%	NULL
(	NULL
mean	NULL
+	NULL
SEM	NULL
;	NULL
n	NULL
=	NULL
4	NULL
)	NULL
by	NULL
IL-7	NULL
.	NULL

The	NULL
addition	NULL
of	NULL
CsA	NULL
partly	NULL
inhibited	NULL
the	NULL
DNA	NULL
binding	NULL
of	NULL
NFAT	NULL
,	NULL
both	NULL
in	NULL
the	NULL
presence	NULL
and	NULL
absence	NULL
of	NULL
IL-7	NULL
;	NULL
only	NULL
a	NULL
basal	NULL
NFAT	NULL
DNA	NULL
binding	NULL
activity	NULL
could	NULL
be	NULL
detected	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
CsA	NULL
.	NULL

This	NULL
result	NULL
is	NULL
reflected	NULL
at	NULL
the	NULL
protein	NULL
level	NULL
.	NULL

In	NULL
the	NULL
presence	NULL
of	NULL
CsA	NULL
,	NULL
the	NULL
IL-2	NULL
secretion	NULL
is	NULL
reduced	NULL
to	NULL
a	NULL
basal	NULL
expression	NULL
level	NULL
:	NULL
PHA/anti-CD28	NULL
activated	NULL
T	NULL
lymphocytes	NULL
secreted	NULL
12,358	NULL
+	NULL
1,094	NULL
pg/mL	NULL
versus	NULL
6,881	NULL
+	NULL
737	NULL
pg/mL	NULL
IL-2	NULL
(	NULL
mean	NULL
+	NULL
SEM	NULL
;	NULL
n	NULL
=	NULL
4	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
CsA	NULL
,	NULL
and	NULL
PHA/anti-CD28	NULL
plus	NULL
IL-7-activated	NULL
T	NULL
lymphocytes	NULL
secreted	NULL
22,955	NULL
+	NULL
364	NULL
pg/mL	NULL
versus	NULL
9,016	NULL
+	NULL
318	NULL
pg/mL	NULL
IL-2	NULL
(	NULL
mean	NULL
+	NULL
SEM	NULL
;	NULL
n	NULL
=	NULL
4	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
CsA	NULL
(	NULL
Fig	NULL
6B	NULL
)	NULL
.	NULL

The	NULL
IL-7	NULL
induced	NULL
enhancement	NULL
of	NULL
the	NULL
AP-1	NULL
DNA	NULL
binding	NULL
activity	NULL
was	NULL
not	NULL
affected	NULL
by	NULL
CsA	NULL
(	NULL
Fig	NULL
6A	NULL
)	NULL
.	NULL

The	NULL
addition	NULL
of	NULL
CsA	NULL
had	NULL
also	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
NFB	NULL
and	NULL
CD28RC	NULL
DNA	NULL
binding	NULL
activities	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
show	NULL
that	NULL
the	NULL
enhanced	NULL
AP-1	NULL
DNA	NULL
binding	NULL
activity	NULL
induced	NULL
by	NULL
IL-7	NULL
is	NULL
not	NULL
mediated	NULL
through	NULL
the	NULL
Ca**-	NULL
and	NULL
cal-modulin-dependent	NULL
signal	NULL
which	NULL
activates	NULL
NFAT1	NULL
.	NULL

DISCUSSION	NULL
In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
have	NULL
examined	NULL
the	NULL
involvement	NULL
of	NULL
the	NULL
stromal-derived	NULL
cytokine	NULL
IL-7	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
IL-2-gene	NULL
expression	NULL
in	NULL
activated	NULL
human	NULL
T	NULL
lymphocytes	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
is	NULL
tightly	NULL
regulated	NULL
at	NULL
the	NULL
transcriptional	NULL
level	NULL
through	NULL
a	NULL
300-bp	NULL
promoter	NULL
containing	NULL
several	NULL
binding	NULL
sites	NULL
for	NULL
both	NULL
ubiquitous	NULL
and	NULL
T-cell	NULL
specific	NULL
transcription	NULL
factors	NULL
.	NULL

We	NULL
demonstrate	NULL
that	NULL
IL-7	NULL
enhances	NULL
the	NULL
expression	NULL
of	NULL
IL-2	NULL
at	NULL
the	NULL
mRNA	NULL
and	NULL
protein	NULL
levels	NULL
most	NULL
pronounced	NULL
in	NULL
PHA	NULL
plus	NULL
anti-CD28	NULL
activated	NULL
T	NULL
lymphocytes	NULL
.	NULL

The	NULL
accumulation	NULL
of	NULL
IL-2	NULL
mRNA	NULL
in	NULL
PHA/anti-CD28	NULL
activated	NULL
T	NULL
lymphocytes	NULL
after	NULL
6	NULL
hours	NULL
of	NULL
stimulation	NULL
is	NULL
about	NULL
fivefold	NULL
increased	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-7	NULL
.	NULL

Previously	NULL
it	NULL
has	NULL
been	NULL
reported	NULL
that	NULL
the	NULL
expression	NULL
of	NULL
another	NULL
Thl-cytokine	NULL
,	NULL
IFN-y	NULL
is	NULL
also	NULL
enhanced	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
IL-7	NULL
.	NULL

``	NULL
°	NULL
Indeed	NULL
,	NULL
we	NULL
observe	NULL
a	NULL
fourfold	NULL
upregulation	NULL
of	NULL
the	NULL
IFN-y	NULL
mRNA	NULL
expression	NULL
by	NULL
PHA/anti-CD28	NULL
stimulated	NULL
T	NULL
lymphocytes	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-7	NULL
.	NULL

The	NULL
effect	NULL
that	NULL
IL-7	NULL
exerts	NULL
on	NULL
the	NULL
IL-2-gene	NULL
expression	NULL
is	NULL
in	NULL
part	NULL
mediated	NULL
at	NULL
the	NULL
transcriptional	NULL
level	NULL
.	NULL

The	NULL
addition	NULL
of	NULL
IL-7	NULL
leads	NULL
to	NULL
a	NULL
3.4-fold	NULL
upregulation	NULL
of	NULL
the	NULL
IL-2-gene	NULL
transcription	NULL
rate	NULL
compared	NULL
with	NULL
the	NULL
transcription	NULL
rate	NULL
induced	NULL
in	NULL
T	NULL
lymphocytes	NULL
stimulated	NULL
with	NULL
PHA	NULL
plus	NULL
anti-CD28	NULL
.	NULL

A	NULL
similar	NULL
effect	NULL
of	NULL
IL-7	NULL
on	NULL
the	NULL
IFN-y	NULL
tran	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

2696	NULL
PHA	NULL
,	NULL
aCD28	NULL
,	NULL
IL-7	NULL
PHA	NULL
,	NULL
aCD28	NULL
,	NULL
IL-7	NULL
``	NULL
D	NULL
f	NULL
S	NULL
3	NULL
E	NULL
+	NULL
®	NULL
=	NULL
3	NULL
PHA	NULL
PHA	NULL
,	NULL
IL-7	NULL
PHA	NULL
aCD28	NULL
urstimulated	NULL
PHA	NULL
PHA	NULL
,	NULL
IL-7	NULL
PHA	NULL
,	NULL
aCD28	NULL
Relative	NULL
NFAT	NULL
DNA	NULL
binding	NULL
Relative	NULL
AP-1	NULL
DNA	NULL
binding	NULL
PHA	NULL
PHA	NULL
,	NULL
IL-7	NULL
PHA	NULL
,	NULL
acD2s	NULL
PHA	NULL
PHA	NULL
,	NULL
aCD28	NULL
,	NULL
IL-7	NULL
PFA	NULL
,	NULL
IL-7	NULL
PHA	NULL
,	NULL
aCD28	NULL
unstimulated	NULL
PHA	NULL
,	NULL
aCD28	NULL
,	NULL
IL-7	NULL
8	NULL
£	NULL
8	NULL
3	NULL
E	NULL
1	NULL
1	NULL
&	NULL
3	NULL
GRINGHUIS	NULL
ET	NULL
AL	NULL
PHA	NULL
aCD28	NULL
PHA	NULL
aCD28	NULL
,	NULL
IL-7	NULL
PHA	NULL
,	NULL
aCD28	NULL
PHA	NULL
,	NULL
aCD28	NULL
,	NULL
IL-7	NULL
O	NULL
$	NULL
8	NULL
S	NULL
s	NULL
)	NULL
3	NULL
3	NULL
E	NULL
E	NULL
£	NULL
3	NULL
&	NULL
£	NULL
£	NULL
3	NULL
3	NULL
PHA	NULL
IL-7	NULL
PHA	NULL
PRA	NULL
IL-7	NULL
PHA	NULL
Relative	NULL
NFkB	NULL
DNA	NULL
binding	NULL
Relative	NULL
CD28RE	NULL
DNA	NULL
binding	NULL
PHA	NULL
&	NULL
t	NULL
<	NULL
T	NULL
&	NULL
unstimulated	NULL
PHA	NULL
,	NULL
IL-7	NULL
U	NULL
$	NULL
S	NULL
3	NULL
E	NULL
E=	NULL
ju	NULL
£	NULL
3	NULL
PHA	NULL
.	NULL

aCD28	NULL
PHA	NULL
,	NULL
aCD28	NULL
,	NULL
IL-7	NULL
PHA	NULL
,	NULL
aCD28	NULL
PHA	NULL
,	NULL
aCD28	NULL
,	NULL
IL-7	NULL
Fig	NULL
4	NULL
.	NULL

DNA	NULL
binding	NULL
activities	NULL
of	NULL
NFAT	NULL
and	NULL
AP-1	NULL
,	NULL
but	NULL
not	NULL
NFB	NULL
and	NULL
CD28RC	NULL
,	NULL
are	NULL
enhanced	NULL
by	NULL
IL-7	NULL
in	NULL
activated	NULL
human	NULL
T	NULL
lymphocytes	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
unstimulated	NULL
T	NULL
cells	NULL
and	NULL
T	NULL
cells	NULL
stimulated	NULL
for	NULL
2	NULL
hours	NULL
with	NULL
PHA	NULL
or	NULL
PHA	NULL
plus	NULL
anti-CD28	NULL
(	NULL
aCD28	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
IL-7	NULL
.	NULL

EMSAs	NULL
were	NULL
performed	NULL
with	NULL
probes	NULL
comprising	NULL
(	NULL
A	NULL
)	NULL
the	NULL
distal	NULL
NFAT	NULL
site	NULL
,	NULL
(	NULL
B	NULL
)	NULL
the	NULL
proximal	NULL
AP-1	NULL
site	NULL
,	NULL
(	NULL
C	NULL
)	NULL
the	NULL
NFB	NULL
site	NULL
,	NULL
and	NULL
(	NULL
D	NULL
)	NULL
the	NULL
CD28	NULL
response	NULL
element	NULL
in	NULL
the	NULL
human	NULL
IL-2	NULL
promoter	NULL
.	NULL

DNA	NULL
binding	NULL
activities	NULL
were	NULL
quantified	NULL
using	NULL
a	NULL
PhosphorImaging	NULL
system	NULL
.	NULL

The	NULL
lower	NULL
graphs	NULL
show	NULL
the	NULL
mean	NULL
+	NULL
SEM	NULL
found	NULL
for	NULL
the	NULL
DNA	NULL
binding	NULL
activities	NULL
of	NULL
NFAT	NULL
,	NULL
AP-1	NULL
,	NULL
NFB	NULL
,	NULL
and	NULL
CD28RE	NULL
in	NULL
four	NULL
independent	NULL
experiments	NULL
.	NULL

The	NULL
results	NULL
are	NULL
expressed	NULL
as	NULL
relative	NULL
DNA	NULL
binding	NULL
compared	NULL
to	NULL
the	NULL
PHA-induced	NULL
DNA	NULL
binding	NULL
,	NULL
which	NULL
was	NULL
set	NULL
at	NULL
1.	NULL
scription	NULL
rate	NULL
has	NULL
previously	NULL
been	NULL
reported	NULL
:	NULL
the	NULL
IFN-y	NULL
transcription	NULL
rate	NULL
in	NULL
anti-CD3/anti-CD28-stimulated	NULL
T	NULL
lymphocytes	NULL
was	NULL
increased	NULL
with	NULL
a	NULL
factor	NULL
2	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-7	NULL
.	NULL
``	NULL

The	NULL
enhanced	NULL
accumulation	NULL
of	NULL
IL-2	NULL
and	NULL
IFN-y	NULL
mRNA	NULL
in	NULL
PHA/anti-CD28	NULL
and	NULL
PHA/anti-CD28	NULL
plus	NULL
IL-7-stimulated	NULL
T	NULL
lymphocytes	NULL
is	NULL
also	NULL
in	NULL
part	NULL
mediated	NULL
at	NULL
the	NULL
post-transcriptional	NULL
level	NULL
.	NULL

It	NULL
has	NULL
been	NULL
reported	NULL
that	NULL
signaling	NULL
via	NULL
CD28	NULL
results	NULL
in	NULL
the	NULL
stabilization	NULL
of	NULL
IL-2	NULL
and	NULL
IFN-y	NULL
mRNA	NULL
.	NULL
``	NULL

In	NULL
addition	NULL
it	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
IL-7	NULL
stabilizes	NULL
the	NULL
mRNAs	NULL
of	NULL
IL-4	NULL
,	NULL
IFN-y	NULL
,	NULL
IL-3	NULL
,	NULL
and	NULL
granulocyte	NULL
macro-phage	NULL
colony-stimulating	NULL
factor	NULL
(	NULL
GM-CSF	NULL
)	NULL
.	NULL
``	NULL

The	NULL
observation	NULL
that	NULL
IL-7	NULL
has	NULL
limited	NULL
effects	NULL
on	NULL
the	NULL
IL-2-mRNA	NULL
accu-	NULL
mulation	NULL
in	NULL
PHA-stimulated	NULL
T_	NULL
lymphocytes	NULL
,	NULL
while	NULL
stimulation	NULL
with	NULL
PHA	NULL
plus	NULL
anti-CD28	NULL
results	NULL
in	NULL
a	NULL
significant	NULL
IL-2-mRNA	NULL
expression	NULL
,	NULL
suggests	NULL
that	NULL
IL-7	NULL
is	NULL
unable	NULL
to	NULL
substitute	NULL
the	NULL
requirement	NULL
for	NULL
CD28	NULL
stimulation	NULL
where	NULL
the	NULL
IL-2	NULL
gene	NULL
is	NULL
concerned	NULL
.	NULL

These	NULL
data	NULL
indicate	NULL
that	NULL
the	NULL
downstream	NULL
targets	NULL
for	NULL
the	NULL
CD28	NULL
and	NULL
IL-7-signaling	NULL
pathways	NULL
are	NULL
differ-ent	NULL
.	NULL

The	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
show	NULL
that	NULL
IL-7	NULL
exerts	NULL
its	NULL
effects	NULL
on	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
IL-2-gene	NULL
expression	NULL
through	NULL
the	NULL
transcription	NULL
factors	NULL
NFAT	NULL
and	NULL
AP-1	NULL
.	NULL

The	NULL
addition	NULL
of	NULL
IL-7	NULL
enhances	NULL
the	NULL
DNA	NULL
binding	NULL
activities	NULL
of	NULL
NFAT	NULL
and	NULL
AP-1	NULL
,	NULL
in	NULL
both	NULL
PHA	NULL
and	NULL
PHA	NULL
plus	NULL
anti-CD28	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

IL-2	NULL
GENE	NULL
REGULATION	NULL
BY	NULL
IL-7	NULL
IN	NULL
T	NULL
CELLS	NULL
2697	NULL
A	NULL
Clurstimulated	NULL
NFAT	NULL
B	NULL
CQunstimulated	NULL
AP-1	NULL
_	NULL
L7	NULL
AIL-7	NULL
7	NULL
‘	NULL
9—	NULL
is	NULL
|	NULL
ER	NULL
PHA	NULL
E	NULL
2	NULL
|-	NULL
MPHA	NULL
Pl	NULL
SPH	NULL
IL-7	NULL
a	NULL
SPHA	NULL
,	NULL
IL-7	NULL
Pol	NULL
J	NULL
15	NULL
s	NULL
%	NULL
x	NULL
9	NULL
}	NULL
5	NULL
G	NULL
0	NULL
ql	NULL
w	NULL
n	NULL
(	NULL
3	NULL
2	NULL
2	NULL
+	NULL
+	NULL
9	NULL
5	NULL
g	NULL
O5	NULL
|-	NULL
i	NULL
Y.	NULL
o5	NULL
T	NULL
lymphocytes	NULL
Fig	NULL
5	NULL
.	NULL

Jurkat	NULL
cells	NULL
25	NULL
IL-7	NULL
enhances	NULL
the	NULL
transcriptional	NULL
activities	NULL
of	NULL
NFAT	NULL
and	NULL
AP-1	NULL
.	NULL

Human	NULL
T	NULL
lymphocytes	NULL
,	NULL
prestimulated	NULL
as	NULL
described	NULL
in	NULL
the	NULL
Materials	NULL
and	NULL
Methods	NULL
section	NULL
,	NULL
and	NULL
the	NULL
T-leukemia	NULL
Jurkat	NULL
cell	NULL
line	NULL
were	NULL
transfected	NULL
with	NULL
20	NULL
ug	NULL
of	NULL
(	NULL
A	NULL
)	NULL
pCAT3e-3	NULL
x	NULL
NFAT/IL-2	NULL
,	NULL
a	NULL
CAT	NULL
reporter	NULL
construct	NULL
under	NULL
the	NULL
control	NULL
of	NULL
three	NULL
copies	NULL
of	NULL
the	NULL
distal	NULL
NFAT	NULL
site	NULL
from	NULL
the	NULL
human	NULL
IL-2	NULL
promoter	NULL
,	NULL
or	NULL
(	NULL
B	NULL
)	NULL
pCAT-3	NULL
x	NULL
AP-1/IL-2	NULL
,	NULL
a	NULL
CAT	NULL
reporter	NULL
construct	NULL
driven	NULL
by	NULL
three	NULL
copies	NULL
of	NULL
the	NULL
AP-1	NULL
site	NULL
from	NULL
the	NULL
IL-2	NULL
promoter	NULL
.	NULL

Transfected	NULL
cells	NULL
were	NULL
left	NULL
alone	NULL
for	NULL
1	NULL
hour	NULL
,	NULL
divided	NULL
in	NULL
four	NULL
groups	NULL
and	NULL
subsequently	NULL
left	NULL
unstimulated	NULL
or	NULL
stimulated	NULL
with	NULL
IL-7	NULL
alone	NULL
,	NULL
PHA	NULL
alone	NULL
or	NULL
PHA	NULL
plus	NULL
IL-7	NULL
for	NULL
24	NULL
hours	NULL
.	NULL

CAT	NULL
expression	NULL
was	NULL
measured	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

The	NULL
results	NULL
are	NULL
expressed	NULL
as	NULL
the	NULL
relative	NULL
CAT	NULL
expression	NULL
compared	NULL
to	NULL
the	NULL
PHA-induced	NULL
CAT	NULL
expression	NULL
,	NULL
which	NULL
was	NULL
set	NULL
at	NULL
1	NULL
.	NULL

The	NULL
IL-7-induced	NULL
CAT	NULL
expression	NULL
in	NULL
Jurkat	NULL
cells	NULL
was	NULL
not	NULL
determined	NULL
(	NULL
ND	NULL
)	NULL
.	NULL

The	NULL
mean	NULL
found	NULL
for	NULL
the	NULL
relative	NULL
CAT	NULL
expression	NULL
in	NULL
three	NULL
to	NULL
six	NULL
independent	NULL
experiments	NULL
is	NULL
shown	NULL
.	NULL

activated	NULL
T	NULL
lymphocytes	NULL
.	NULL

The	NULL
NFAT	NULL
DNA	NULL
binding	NULL
activity	NULL
is	NULL
enhanced	NULL
with	NULL
a	NULL
factor	NULL
1.6	NULL
,	NULL
while	NULL
the	NULL
AP-1	NULL
DNA	NULL
binding	NULL
activity	NULL
is	NULL
more	NULL
than	NULL
twofold	NULL
enhanced	NULL
.	NULL

The	NULL
effects	NULL
of	NULL
IL-7	NULL
are	NULL
specific	NULL
since	NULL
the	NULL
DNA	NULL
binding	NULL
activities	NULL
of	NULL
CD28RC	NULL
and	NULL
NFB	NULL
are	NULL
not	NULL
affected	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
IL-7	NULL
.	NULL

However	NULL
,	NULL
the	NULL
enhanced	NULL
binding	NULL
of	NULL
NFAT	NULL
and	NULL
AP-1	NULL
to	NULL
the	NULL
IL-2	NULL
promoter	NULL
induced	NULL
by	NULL
IL-7	NULL
in	NULL
PHA/IL-7-stimulated	NULL
T	NULL
lymphocytes	NULL
has	NULL
limited	NULL
effects	NULL
at	NULL
mRNA	NULL
and	NULL
protein	NULL
level	NULL
.	NULL

Coacti-vation	NULL
with	NULL
anti-CD28	NULL
is	NULL
required	NULL
for	NULL
a	NULL
significant	NULL
increase	NULL
in	NULL
the	NULL
IL-2-mRNA	NULL
accumulation	NULL
and	NULL
protein	NULL
secretion	NULL
.	NULL

In	NULL
T	NULL
lymphocytes	NULL
stimulated	NULL
with	NULL
PHA	NULL
alone	NULL
or	NULL
PHA	NULL
plus	NULL
IL-7	NULL
,	NULL
a	NULL
DNA	NULL
binding	NULL
activity	NULL
to	NULL
the	NULL
CD28	NULL
response	NULL
element	NULL
(	NULL
CD28RE	NULL
)	NULL
is	NULL
observed	NULL
.	NULL

Several	NULL
reports	NULL
have	NULL
presented	NULL
evidence	NULL
that	NULL
binding	NULL
to	NULL
CD28RE	NULL
might	NULL
occur	NULL
in	NULL
response	NULL
to	NULL
TCR	NULL
sig-	NULL
A	NULL
Fig	NULL
6	NULL
.	NULL

The	NULL
enhanced	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
AP-1	NULL
induced	NULL
by	NULL
IL-7	NULL
in	NULL
activated	NULL
human	NULL
T	NULL
lymphocytes	NULL
is	NULL
CsA-resistant	NULL
,	NULL
while	NULL
the	NULL
NFAT	NULL
DNA	NULL
binding	NULL
activity	NULL
is	NULL
CsA-sensitive	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
T	NULL
cells	NULL
stimulated	NULL
for	NULL
2	NULL
hours	NULL
with	NULL
PHA	NULL
plus	NULL
anti-CD28	NULL
(	NULL
aCD28	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
IL-7	NULL
.	NULL

CsA	NULL
was	NULL
added	NULL
30	NULL
minutes	NULL
before	NULL
stimulation	NULL
.	NULL

EMSAs	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
in	NULL
Fig	NULL
3	NULL
.	NULL

(	NULL
B	NULL
)	NULL
At	NULL
the	NULL
same	NULL
time	NULL
,	NULL
cells	NULL
were	NULL
stimulated	NULL
for	NULL
24	NULL
hours	NULL
for	NULL
IL-2-secretion	NULL
|	NULL
measurements	NULL
.	NULL

The	NULL
mean	NULL
for	NULL
the	NULL
IL-2	NULL
secretion	NULL
found	NULL
in	NULL
four	NULL
independent	NULL
experiments	NULL
is	NULL
shown	NULL
.	NULL

PHA	NULL
,	NULL
acCD28	NULL
PHA	NULL
,	NULL
aCD28	NULL
+CsA	NULL
PHA	NULL
,	NULL
acCD28	NULL
,	NULL
IL-7	NULL
NFAT	NULL
Egg	NULL
*-	NULL
jaw	NULL
~-	NULL
C	NULL
WW	NULL
nals	NULL
.	NULL
``	NULL

Recently	NULL
a	NULL
35-KD	NULL
inducible	NULL
protein	NULL
was	NULL
identified	NULL
and	NULL
called	NULL
NF-MAT	NULL
.	NULL
``	NULL

This	NULL
factor	NULL
is	NULL
most	NULL
likely	NULL
responsible	NULL
for	NULL
the	NULL
observed	NULL
binding	NULL
to	NULL
the	NULL
CD28RE	NULL
.	NULL

After	NULL
costimulation	NULL
with	NULL
anti-CD28	NULL
,	NULL
the	NULL
CD28	NULL
signal	NULL
induces	NULL
the	NULL
binding	NULL
of	NULL
the	NULL
CD28	NULL
responsive	NULL
complex	NULL
(	NULL
CD28RC	NULL
)	NULL
to	NULL
the	NULL
CD28RE	NULL
,	NULL
which	NULL
initiates	NULL
the	NULL
IL-2	NULL
production	NULL
by	NULL
the	NULL
activated	NULL
T	NULL
lymphocytes	NULL
.	NULL

This	NULL
result	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
observations	NULL
that	NULL
T	NULL
lymphocytes	NULL
need	NULL
the	NULL
costimulatory	NULL
CD28	NULL
signal	NULL
to	NULL
produce	NULL
IL-2	NULL
,	NULL
and	NULL
suggests	NULL
that	NULL
the	NULL
increase	NULL
in	NULL
DNA	NULL
binding	NULL
to	NULL
CD28RE	NULL
is	NULL
most	NULL
relevant	NULL
for	NULL
the	NULL
ongoing	NULL
transactivation	NULL
.	NULL
``	NULL

The	NULL
results	NULL
obtained	NULL
with	NULL
the	NULL
mobility	NULL
shift	NULL
assays	NULL
,	NULL
indicating	NULL
that	NULL
IL-7	NULL
affects	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
through	NULL
the	NULL
DNA	NULL
binding	NULL
activities	NULL
of	NULL
NFAT	NULL
and	NULL
AP-1	NULL
,	NULL
could	NULL
be	NULL
confirmed	NULL
by	NULL
transfection	NULL
studies	NULL
.	NULL

K	NULL
B	NULL
25000	NULL
U	NULL
4	NULL
§-CsA	NULL
iin	NULL
a	NULL
20000	NULL
|	NULL
-	NULL
E	NULL
r	NULL
%	NULL
a	NULL
S	NULL
A	NULL
<	NULL
1s000	NULL
|	NULL
U	NULL
:	NULL
o	NULL
0	NULL
+-A	NULL
®	NULL
¢	NULL
§	NULL
1000	NULL
1000	NULL
&	NULL
®	NULL
a	NULL
=	NULL
!	NULL

_	NULL
sooo	NULL
|	NULL
o	NULL
PHAaCD28	NULL
PHAaCD2S	NULL
+	NULL
IL-7	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

2698	NULL
Since	NULL
AP-1	NULL
forms	NULL
a	NULL
part	NULL
of	NULL
the	NULL
NFAT	NULL
complex	NULL
that	NULL
binds	NULL
to	NULL
the	NULL
human	NULL
IL-2	NULL
promoter	NULL
,	NULL
``	NULL
the	NULL
results	NULL
strongly	NULL
suggest	NULL
that	NULL
the	NULL
IL-7	NULL
induced	NULL
NFAT	NULL
DNA	NULL
binding	NULL
activity	NULL
is	NULL
regulated	NULL
through	NULL
the	NULL
AP-1	NULL
component	NULL
of	NULL
the	NULL
NFAT	NULL
complex	NULL
.	NULL

This	NULL
implicates	NULL
that	NULL
the	NULL
IL-7-signaling	NULL
pathway	NULL
leads	NULL
to	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
AP-1	NULL
proteins	NULL
fos	NULL
and	NULL
jun	NULL
.	NULL
``	NULL

Only	NULL
limited	NULL
data	NULL
are	NULL
available	NULL
about	NULL
the	NULL
signaling	NULL
pathways	NULL
of	NULL
IL-7	NULL
.	NULL

JAK1	NULL
,	NULL
JAK3	NULL
,	NULL
and	NULL
STATS	NULL
have	NULL
been	NULL
demonstrated	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
IL-7	NULL
signaling	NULL
and	NULL
so	NULL
have	NULL
the	NULL
protein	NULL
tyrosine	NULL
kinases	NULL
p56	NULL
``	NULL
and	NULL
p59	NULL
``	NULL
,	NULL
and	NULL
PI	NULL
3-kinase	NULL
.	NULL
``	NULL

'	NULL
``	NULL
``	NULL
The	NULL
activation	NULL
of	NULL
MAPK	NULL
by	NULL
IL-7	NULL
has	NULL
been	NULL
reported	NULL
once	NULL
.	NULL
``	NULL

''	NULL
The	NULL
signal	NULL
transduction	NULL
pathways	NULL
leading	NULL
to	NULL
the	NULL
activation	NULL
of	NULL
fos	NULL
and	NULL
jun	NULL
proteins	NULL
are	NULL
better	NULL
known	NULL
.	NULL

The	NULL
kinase	NULL
p21	NULL
``	NULL
(	NULL
Ras	NULL
)	NULL
plays	NULL
a	NULL
central	NULL
role	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
AP-1	NULL
proteins	NULL
through	NULL
the	NULL
induction	NULL
of	NULL
at	NULL
least	NULL
two	NULL
kinase	NULL
cascades	NULL
,	NULL
which	NULL
are	NULL
both	NULL
critical	NULL
to	NULL
NFAT	NULL
activation	NULL
and	NULL
T-cell	NULL
activation	NULL
.	NULL
``	NULL

Firstly	NULL
,	NULL
Ras	NULL
activates	NULL
the	NULL
Raf-1/MEK/ERK	NULL
(	NULL
extracellular	NULL
signal	NULL
regulated	NULL
kinase	NULL
)	NULL
cascade	NULL
,	NULL
resulting	NULL
in	NULL
the	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
c-fos	NULL
promoter	NULL
.	NULL

The	NULL
production	NULL
of	NULL
c-fos	NULL
contributes	NULL
directly	NULL
to	NULL
the	NULL
induction	NULL
of	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
AP-1	NULL
,	NULL
since	NULL
fos/jun	NULL
heterodimers	NULL
are	NULL
much	NULL
more	NULL
efficient	NULL
in	NULL
binding	NULL
to	NULL
DNA	NULL
than	NULL
jun/jun	NULL
homodimers	NULL
.	NULL
``	NULL

The	NULL
second	NULL
pathway	NULL
induced	NULL
by	NULL
Ras	NULL
involves	NULL
the	NULL
MEKK/SEK/JNK	NULL
(	NULL
c-jun	NULL
NH	NULL
;	NULL
-terminal	NULL
kinase	NULL
)	NULL
cascade	NULL
which	NULL
results	NULL
both	NULL
in	NULL
the	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
c-jun	NULL
promoter	NULL
as	NULL
also	NULL
in	NULL
the	NULL
stimulation	NULL
of	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
c-jun	NULL
.	NULL
'	NULL

''	NULL
``	NULL
**	NULL
``	NULL
The	NULL
IL-7	NULL
induced	NULL
signaling	NULL
pathway	NULL
can	NULL
activate	NULL
either	NULL
one	NULL
of	NULL
the	NULL
signaling	NULL
proteins	NULL
involved	NULL
in	NULL
the	NULL
ERK	NULL
and	NULL
JNK	NULL
pathways	NULL
.	NULL

We	NULL
speculate	NULL
that	NULL
Raf-1	NULL
is	NULL
not	NULL
a	NULL
target	NULL
for	NULL
the	NULL
IL-7	NULL
signal	NULL
,	NULL
since	NULL
Raf-1	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
NFKB/	NULL
Rel	NULL
proteins	NULL
.	NULL

Activated	NULL
Raf-1	NULL
induces	NULL
the	NULL
degradation	NULL
of	NULL
IB	NULL
proteins	NULL
which	NULL
sequester	NULL
NFB	NULL
proteins	NULL
in	NULL
the	NULL
cytoplasm	NULL
.	NULL
``	NULL

The	NULL
activation	NULL
of	NULL
Raf-1	NULL
by	NULL
IL-7	NULL
either	NULL
direct	NULL
or	NULL
via	NULL
Ras	NULL
,	NULL
would	NULL
subsequently	NULL
result	NULL
in	NULL
an	NULL
upregulation	NULL
of	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
NFB	NULL
.	NULL

Our	NULL
results	NULL
show	NULL
that	NULL
the	NULL
NFB	NULL
DNA	NULL
binding	NULL
activity	NULL
is	NULL
not	NULL
affected	NULL
by	NULL
IL-7	NULL
.	NULL

However	NULL
,	NULL
this	NULL
does	NULL
not	NULL
exclude	NULL
the	NULL
possibility	NULL
that	NULL
proteins	NULL
downstream	NULL
of	NULL
Raf-1	NULL
are	NULL
involved	NULL
in	NULL
the	NULL
IL-7-signaling	NULL
pathway	NULL
.	NULL

Further	NULL
experiments	NULL
are	NULL
necessary	NULL
to	NULL
gain	NULL
insight	NULL
in	NULL
which	NULL
signaling	NULL
proteins	NULL
are	NULL
involved	NULL
in	NULL
the	NULL
IL-7-induced	NULL
activation	NULL
of	NULL
fos	NULL
and	NULL
jun	NULL
proteins	NULL
.	NULL

The	NULL
immunosuppressive	NULL
drug	NULL
CsA	NULL
does	NULL
not	NULL
block	NULL
the	NULL
IL-7	NULL
induced	NULL
,	NULL
enhanced	NULL
DNA	NULL
binding	NULL
of	NULL
AP-1	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
IL-7-signaling	NULL
pathway	NULL
is	NULL
not	NULL
a	NULL
CsA-sensitive	NULL
pathway	NULL
.	NULL

This	NULL
is	NULL
consistent	NULL
with	NULL
a	NULL
role	NULL
for	NULL
the	NULL
ERK	NULL
pathway	NULL
in	NULL
the	NULL
signal	NULL
transduction	NULL
route	NULL
of	NULL
IL-7	NULL
,	NULL
since	NULL
this	NULL
pathway	NULL
is	NULL
not	NULL
inhibited	NULL
by	NULL
CsA	NULL
.	NULL
``	NULL

Activation	NULL
of	NULL
JNK	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
partially	NULL
sensitive	NULL
to	NULL
CsA	NULL
.	NULL
``	NULL

Some	NULL
jun	NULL
family	NULL
members	NULL
,	NULL
distinct	NULL
from	NULL
AP-1	NULL
activity	NULL
,	NULL
are	NULL
activated	NULL
by	NULL
a	NULL
calcium-regulated	NULL
,	NULL
CsA-sensitive	NULL
signaling	NULL
pathway	NULL
.	NULL
``	NULL

IL-7	NULL
seems	NULL
not	NULL
to	NULL
use	NULL
this	NULL
pathway	NULL
to	NULL
activate	NULL
jun	NULL
proteins	NULL
.	NULL

IL-7	NULL
might	NULL
also	NULL
regulate	NULL
the	NULL
expression	NULL
of	NULL
c-fos	NULL
through	NULL
activation	NULL
of	NULL
a	NULL
JAK/STAT	NULL
pathway	NULL
.	NULL

Recently	NULL
a	NULL
role	NULL
for	NULL
STATS5	NULL
has	NULL
been	NULL
proposed	NULL
in	NULL
the	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
c-fos	NULL
promoter	NULL
.	NULL

Evidence	NULL
was	NULL
presented	NULL
showing	NULL
that	NULL
both	NULL
Ras-mediated	NULL
and	NULL
STATS	NULL
signals	NULL
are	NULL
necessary	NULL
for	NULL
the	NULL
full	NULL
expression	NULL
of	NULL
c-fos	NULL
.	NULL
``	NULL

Since	NULL
IL-7	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
induce	NULL
the	NULL
activation	NULL
of	NULL
JAK3	NULL
and	NULL
STAT5	NULL
,	NULL
*	NULL
``	NULL
it	NULL
seems	NULL
possible	NULL
that	NULL
IL-7	NULL
upregulates	NULL
the	NULL
c-fos	NULL
expression	NULL
through	NULL
activation	NULL
of	NULL
STATS	NULL
.	NULL

GRINGHUIS	NULL
ET	NULL
AL	NULL
Thus	NULL
,	NULL
we	NULL
conclude	NULL
that	NULL
IL-7	NULL
upregulates	NULL
the	NULL
IL-2-gene	NULL
expression	NULL
by	NULL
enhancing	NULL
the	NULL
DNA	NULL
binding	NULL
activities	NULL
of	NULL
both	NULL
NFAT	NULL
and	NULL
AP-1	NULL
to	NULL
the	NULL
IL-2	NULL
promoter	NULL
.	NULL

We	NULL
speculate	NULL
that	NULL
the	NULL
IL-7-signaling	NULL
pathways	NULL
cross-talk	NULL
with	NULL
other	NULL
signaling	NULL
pathways	NULL
that	NULL
activate	NULL
the	NULL
fos	NULL
and	NULL
jun	NULL
proteins	NULL
,	NULL
since	NULL
both	NULL
proteins	NULL
are	NULL
part	NULL
of	NULL
the	NULL
NFAT	NULL
and	NULL
AP-1-transcription	NULL
factors	NULL
.	NULL

ACKNOWLEDGMENT	NULL
We	NULL
thank	NULL
Dr	NULL
C.L	NULL
.	NULL

Verweij	NULL
for	NULL
providing	NULL
the	NULL
p22.6CAT	NULL
and	NULL
pX3-CAT	NULL
plasmids	NULL
,	NULL
Dr	NULL
E.G.E	NULL
.	NULL

de	NULL
Vries	NULL
for	NULL
providing	NULL
the	NULL
IL-2	NULL
cDNA	NULL
probe	NULL
,	NULL
and	NULL
Dr	NULL
C.B	NULL
.	NULL

Wilson	NULL
for	NULL
the	NULL
IFN-y	NULL
cDNA	NULL
probe	NULL
.	NULL

We	NULL
also	NULL
thank	NULL
Dr	NULL
S.C.	NULL
Clark	NULL
for	NULL
the	NULL
supply	NULL
of	NULL
rhIL-7	NULL
.	NULL

We	NULL
are	NULL
grateful	NULL
to	NULL
M.T	NULL
.	NULL

Esselink	NULL
for	NULL
performing	NULL
some	NULL
of	NULL
the	NULL
Northern	NULL
hybridizations	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Durand	NULL
DB	NULL
,	NULL
Shaw	NULL
J-P	NULL
,	NULL
Bush	NULL
MR	NULL
,	NULL
Replogle	NULL
RE	NULL
,	NULL
Belagaje	NULL
R	NULL
,	NULL
Crabtree	NULL
GR	NULL
:	NULL
Characterization	NULL
of	NULL
antigen	NULL
response	NULL
elements	NULL
within	NULL
the	NULL
interleukin-2	NULL
enhancer	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
8:1715	NULL
,	NULL
1988	NULL
2	NULL
.	NULL

Jain	NULL
J	NULL
,	NULL
Loh	NULL
C	NULL
,	NULL
Rao	NULL
A	NULL
:	NULL
Transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
.	NULL

Curr	NULL
Opin	NULL
Immunol	NULL
7:333	NULL
,	NULL
1995	NULL
3	NULL
.	NULL

Garrity	NULL
PA	NULL
,	NULL
Chen	NULL
D	NULL
,	NULL
Rothenberg	NULL
EV	NULL
,	NULL
Wold	NULL
BJ	NULL
:	NULL
Interleukin-2	NULL
transcription	NULL
is	NULL
regulated	NULL
in	NULL
vivo	NULL
at	NULL
the	NULL
level	NULL
of	NULL
coordinated	NULL
binding	NULL
of	NULL
both	NULL
constitutive	NULL
and	NULL
regulated	NULL
factors	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
14:2159	NULL
,	NULL
1994	NULL
4	NULL
.	NULL

McCaffrey	NULL
PG	NULL
,	NULL
Luo	NULL
C	NULL
,	NULL
Kerppola	NULL
TK	NULL
,	NULL
Jain	NULL
J	NULL
,	NULL
Badalian	NULL
TM	NULL
,	NULL
Ho	NULL
AM	NULL
,	NULL
Burgeon	NULL
E	NULL
,	NULL
Lane	NULL
WS	NULL
,	NULL
Lambert	NULL
JM	NULL
,	NULL
Curran	NULL
T	NULL
,	NULL
Verdine	NULL
GL	NULL
,	NULL
Rao	NULL
A	NULL
,	NULL
Hogan	NULL
PG	NULL
:	NULL
Isolation	NULL
of	NULL
the	NULL
cyclosporin-sensitive	NULL
T	NULL
cell	NULL
transcription	NULL
factor	NULL
NFATp	NULL
.	NULL

Science	NULL
262:750	NULL
,	NULL
1993	NULL
5	NULL
.	NULL

Boise	NULL
LH	NULL
,	NULL
Petryniak	NULL
B	NULL
,	NULL
Mao	NULL
X	NULL
,	NULL
June	NULL
SH	NULL
,	NULL
Wang	NULL
CY	NULL
,	NULL
Lindsten	NULL
T	NULL
,	NULL
Bravo	NULL
R	NULL
,	NULL
Kovary	NULL
K	NULL
,	NULL
Leiden	NULL
JH	NULL
,	NULL
Thompson	NULL
CB	NULL
:	NULL
The	NULL
NFAT-1	NULL
DNA	NULL
binding	NULL
complex	NULL
in	NULL
activated	NULL
T	NULL
cells	NULL
contains	NULL
Fra-1	NULL
and	NULL
JunB	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
13:1911	NULL
,	NULL
1993	NULL
6	NULL
.	NULL

Emmel	NULL
EA	NULL
,	NULL
Verweij	NULL
CL	NULL
,	NULL
Durand	NULL
DB	NULL
,	NULL
Higgins	NULL
KM	NULL
,	NULL
Lacy	NULL
E	NULL
,	NULL
Crabtree	NULL
GR	NULL
:	NULL
Cyclosporin	NULL
A	NULL
specifically	NULL
inhibits	NULL
function	NULL
of	NULL
nuclear	NULL
proteins	NULL
involved	NULL
in	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

Science	NULL
246:1617	NULL
,	NULL
1989	NULL
7	NULL
.	NULL

Ullman	NULL
KS	NULL
,	NULL
Flanagan	NULL
WM	NULL
,	NULL
Edwards	NULL
CA	NULL
,	NULL
Crabtree	NULL
GR	NULL
:	NULL
Activation	NULL
of	NULL
early	NULL
gene	NULL
expression	NULL
in	NULL
T	NULL
lymphocytes	NULL
by	NULL
Oct-1	NULL
and	NULL
an	NULL
inducible	NULL
protein	NULL
,	NULL
OAPA4O	NULL
.	NULL

Science	NULL
254:558	NULL
,	NULL
1991	NULL
8	NULL
.	NULL

Ullman	NULL
KS	NULL
,	NULL
Northrop	NULL
JP	NULL
,	NULL
Admon	NULL
A	NULL
,	NULL
Crabtree	NULL
GR	NULL
:	NULL
Jun	NULL
family	NULL
members	NULL
are	NULL
controlled	NULL
by	NULL
a	NULL
calcium-regulated	NULL
,	NULL
cyclosporin	NULL
A-sensi-tive	NULL
signaling	NULL
pathway	NULL
in	NULL
activated	NULL
T	NULL
lymphocytes	NULL
.	NULL

Genes	NULL
Dev	NULL
7:188	NULL
,	NULL
1993	NULL
9	NULL
.	NULL

Fraser	NULL
JD	NULL
,	NULL
Irving	NULL
BA	NULL
,	NULL
Crabtree	NULL
GR	NULL
,	NULL
Weiss	NULL
A	NULL
:	NULL
Regulation	NULL
of	NULL
interleukin-2	NULL
gene	NULL
enhancer	NULL
activity	NULL
by	NULL
the	NULL
T	NULL
cell	NULL
accessory	NULL
molecule	NULL
CD28	NULL
.	NULL

Science	NULL
251:313	NULL
,	NULL
1991	NULL
10	NULL
.	NULL

Verweij	NULL
CL	NULL
,	NULL
Geerts	NULL
M	NULL
,	NULL
Aarden	NULL
LA	NULL
:	NULL
Activation	NULL
of	NULL
interleukin-2	NULL
gene	NULL
transcription	NULL
via	NULL
the	NULL
T-cell	NULL
surface	NULL
molecule	NULL
CD28	NULL
is	NULL
mediated	NULL
through	NULL
an	NULL
NF-	NULL
«	NULL
B-like	NULL
response	NULL
element	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
266:14179	NULL
,	NULL
1991	NULL
11	NULL
.	NULL

Civil	NULL
A	NULL
,	NULL
Bakker	NULL
A	NULL
,	NULL
Rensink	NULL
I	NULL
,	NULL
Doerre	NULL
S	NULL
,	NULL
Aarden	NULL
LA	NULL
,	NULL
Verweij	NULL
CL	NULL
:	NULL
Nuclear	NULL
appearance	NULL
of	NULL
a	NULL
factor	NULL
that	NULL
binds	NULL
the	NULL
CD28	NULL
response	NULL
element	NULL
within	NULL
the	NULL
interleukin-2	NULL
enhancer	NULL
correlates	NULL
with	NULL
interleukin-2	NULL
production	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
271:8321	NULL
,	NULL
1996	NULL
12	NULL
.	NULL

Li	NULL
M	NULL
,	NULL
Sieckevitz	NULL
M	NULL
:	NULL
A	NULL
cis	NULL
element	NULL
required	NULL
for	NULL
induction	NULL
of	NULL
the	NULL
interleukin	NULL
2	NULL
enhancer	NULL
by	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
binds	NULL
a	NULL
novel	NULL
Tax-inducible	NULL
nuclear	NULL
protein	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
13:6490	NULL
,	NULL
1993	NULL
13	NULL
.	NULL

Rao	NULL
A	NULL
:	NULL
NF-ATp	NULL
:	NULL
A	NULL
transcription	NULL
factor	NULL
required	NULL
for	NULL
the	NULL
coordinate	NULL
induction	NULL
of	NULL
several	NULL
cytokine	NULL
genes	NULL
.	NULL

Immunol	NULL
Today	NULL
15:274	NULL
,	NULL
1994	NULL
14	NULL
.	NULL

Loh	NULL
C	NULL
,	NULL
Shaw	NULL
KTY	NULL
,	NULL
Caren	NULL
J	NULL
,	NULL
Viola	NULL
JPB	NULL
,	NULL
Luo	NULL
C	NULL
,	NULL
Perrino	NULL
BA	NULL
,	NULL
Rao	NULL
A	NULL
:	NULL
Calcineurin	NULL
binds	NULL
the	NULL
transcription	NULL
factor	NULL
NFAT1	NULL
and	NULL
revers-ibly	NULL
regulates	NULL
its	NULL
activity	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
271:10884	NULL
,	NULL
1996	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

IL-2	NULL
GENE	NULL
REGULATION	NULL
BY	NULL
IL-7	NULL
IN	NULL
T	NULL
CELLS	NULL
15	NULL
.	NULL

McCaffrey	NULL
PG	NULL
,	NULL
Perrino	NULL
BA	NULL
,	NULL
Soderling	NULL
TR	NULL
,	NULL
Rao	NULL
A	NULL
:	NULL
NF-ATp	NULL
,	NULL
a	NULL
T	NULL
lymphocyte	NULL
DNA-binding	NULL
protein	NULL
that	NULL
is	NULL
a	NULL
target	NULL
for	NULL
calcineurin	NULL
and	NULL
immunosuppressive	NULL
drugs	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
268:3747	NULL
,	NULL
1993	NULL
16	NULL
.	NULL

Shaw	NULL
KTY	NULL
,	NULL
Ho	NULL
AM	NULL
,	NULL
Raghavan	NULL
A	NULL
,	NULL
Kim	NULL
J	NULL
,	NULL
Jain	NULL
J	NULL
,	NULL
Park	NULL
J	NULL
,	NULL
Sharma	NULL
S	NULL
,	NULL
Rao	NULL
A	NULL
,	NULL
Hogan	NULL
PG	NULL
:	NULL
Immunosuppressive	NULL
drugs	NULL
prevent	NULL
a	NULL
rapid	NULL
dephosphorylation	NULL
of	NULL
transcription	NULL
factor	NULL
NFAT1	NULL
in	NULL
stimulated	NULL
immune	NULL
cells	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
92:11205	NULL
,	NULL
1995	NULL
17	NULL
.	NULL

Sanchez	NULL
I	NULL
,	NULL
Hughes	NULL
RT	NULL
,	NULL
Mayer	NULL
BJ	NULL
,	NULL
Yee	NULL
K	NULL
,	NULL
Woodgett	NULL
JW	NULL
,	NULL
Avruch	NULL
J	NULL
,	NULL
Kyriakis	NULL
JM	NULL
,	NULL
Zon	NULL
LI	NULL
:	NULL
Role	NULL
of	NULL
SAPK/ERK	NULL
kinase	NULL
in	NULL
the	NULL
stress-activated	NULL
pathway	NULL
regulating	NULL
transcription	NULL
factor	NULL
c-jun	NULL
.	NULL

Nature	NULL
372:794	NULL
,	NULL
1994	NULL
18	NULL
.	NULL

Westwick	NULL
JK	NULL
,	NULL
Cox	NULL
AD	NULL
,	NULL
Der	NULL
CJ	NULL
,	NULL
Cobb	NULL
MH	NULL
,	NULL
Hibi	NULL
M	NULL
,	NULL
Karin	NULL
M	NULL
,	NULL
Brenner	NULL
DA	NULL
:	NULL
Oncogenic	NULL
Ras	NULL
activates	NULL
c-Jun	NULL
via	NULL
a	NULL
separate	NULL
pathway	NULL
from	NULL
the	NULL
activation	NULL
of	NULL
extracellular	NULL
signal-regulated	NULL
kinases	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
91:6030	NULL
,	NULL
1994	NULL
19	NULL
.	NULL

Karin	NULL
M	NULL
:	NULL
The	NULL
regulation	NULL
of	NULL
AP-1	NULL
activity	NULL
by	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
270:16483	NULL
,	NULL
1995	NULL
20	NULL
.	NULL

Deng	NULL
T	NULL
,	NULL
Karin	NULL
M	NULL
:	NULL
c-Fos	NULL
transcriptional	NULL
activity	NULL
stimulated	NULL
by	NULL
H-Ras-activated	NULL
protein	NULL
kinase	NULL
distinct	NULL
from	NULL
JNK	NULL
and	NULL
ERK	NULL
.	NULL

Nature	NULL
371:171	NULL
,	NULL
1994	NULL
21	NULL
.	NULL

Grabstein	NULL
KH	NULL
,	NULL
Waldschmidt	NULL
TJ	NULL
,	NULL
Finkelman	NULL
FD	NULL
,	NULL
Hess	NULL
BW	NULL
,	NULL
Alpert	NULL
AR	NULL
,	NULL
Bolani	NULL
NE	NULL
,	NULL
Namen	NULL
AE	NULL
:	NULL
Inhibition	NULL
of	NULL
murine	NULL
B	NULL
and	NULL
T	NULL
lymphopoiesis	NULL
in	NULL
vivo	NULL
by	NULL
an	NULL
anti-interleukin	NULL
7	NULL
monoclonal	NULL
antibody	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
178:257	NULL
,	NULL
1993	NULL
22	NULL
.	NULL

Peschon	NULL
JJ	NULL
,	NULL
Morrissey	NULL
PJ	NULL
,	NULL
Grabstein	NULL
KH	NULL
,	NULL
Ramsdell	NULL
FJ	NULL
,	NULL
Mara-skowsky	NULL
E	NULL
,	NULL
Gliniak	NULL
BC	NULL
,	NULL
Park	NULL
LS	NULL
,	NULL
Ziegler	NULL
SF	NULL
,	NULL
Williams	NULL
DE	NULL
,	NULL
Ware	NULL
CB	NULL
,	NULL
Meyer	NULL
JD	NULL
,	NULL
Davison	NULL
BL	NULL
:	NULL
Early	NULL
lymphocyte	NULL
expansion	NULL
is	NULL
severely	NULL
impaired	NULL
in	NULL
interleukin	NULL
7	NULL
receptor-deficient	NULL
mice	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
180:1955	NULL
,	NULL
1994	NULL
23	NULL
.	NULL

Armitage	NULL
RJ	NULL
,	NULL
Namen	NULL
AE	NULL
,	NULL
Sassenfeld	NULL
HM	NULL
,	NULL
Grabstein	NULL
KH	NULL
:	NULL
Regulation	NULL
of	NULL
human	NULL
T	NULL
cell	NULL
proliferation	NULL
by	NULL
IL-7	NULL
.	NULL

J	NULL
Immunol	NULL
144:938	NULL
,	NULL
1990	NULL
24	NULL
.	NULL

Naume	NULL
B	NULL
,	NULL
Johnsen	NULL
AC	NULL
,	NULL
Espevik	NULL
T	NULL
,	NULL
Sundan	NULL
A	NULL
:	NULL
Gene	NULL
expression	NULL
and	NULL
secretion	NULL
of	NULL
cytokines	NULL
and	NULL
cytokine	NULL
receptors	NULL
from	NULL
highly	NULL
purified	NULL
CDS56+	NULL
natural	NULL
killer	NULL
cells	NULL
stimulated	NULL
with	NULL
interleukin-2	NULL
,	NULL
interleukin-7	NULL
and	NULL
interleukin-12	NULL
.	NULL

Eur	NULL
J	NULL
Immunol	NULL
23:1831	NULL
,	NULL
1993	NULL
25	NULL
.	NULL

Kondo	NULL
M	NULL
,	NULL
Takeshita	NULL
T	NULL
,	NULL
Higuchi	NULL
M	NULL
,	NULL
Nakamura	NULL
M	NULL
,	NULL
Sudo	NULL
T	NULL
,	NULL
Nishikawa	NULL
S-I	NULL
,	NULL
Sugamura	NULL
K	NULL
:	NULL
Functional	NULL
participation	NULL
of	NULL
the	NULL
IL-2	NULL
receptor	NULL
y	NULL
chain	NULL
in	NULL
IL-7	NULL
receptor	NULL
complexes	NULL
.	NULL

Science	NULL
263:1453	NULL
,	NULL
1994	NULL
26	NULL
.	NULL

Borger	NULL
P	NULL
,	NULL
Kauffman	NULL
HF	NULL
,	NULL
Postma	NULL
DS	NULL
,	NULL
Vellenga	NULL
E	NULL
:	NULL
IL-7	NULL
differ-entially	NULL
modulates	NULL
the	NULL
expression	NULL
of	NULL
IFN-y	NULL
and	NULL
IL-4	NULL
in	NULL
activated	NULL
human	NULL
T	NULL
lymphocytes	NULL
by	NULL
transcriptional	NULL
and	NULL
post-transcriptional	NULL
mechanisms	NULL
.	NULL

J	NULL
Immunol	NULL
156:1333	NULL
,	NULL
1996	NULL
27	NULL
.	NULL

Dokter	NULL
WHA	NULL
,	NULL
Sierdsema	NULL
SJ	NULL
,	NULL
Esselink	NULL
MT	NULL
,	NULL
Halie	NULL
MR	NULL
,	NULL
Vellenga	NULL
E	NULL
:	NULL
Interleukin-4	NULL
mRNA	NULL
and	NULL
protein	NULL
in	NULL
activated	NULL
human	NULL
T	NULL
cells	NULL
are	NULL
enhanced	NULL
by	NULL
interleukin-7	NULL
.	NULL

Exp	NULL
Hematol	NULL
22:74	NULL
,	NULL
1994	NULL
28	NULL
.	NULL

Vellenga	NULL
E	NULL
,	NULL
Rambaldi	NULL
A	NULL
,	NULL
Emmst	NULL
TJ	NULL
,	NULL
Ostapoviez	NULL
D	NULL
,	NULL
Griffin	NULL
JD	NULL
:	NULL
Independent	NULL
regulation	NULL
of	NULL
M-CSF	NULL
and	NULL
G-CSF	NULL
gene	NULL
expression	NULL
in	NULL
human	NULL
monocytes	NULL
.	NULL

Blood	NULL
71:1529	NULL
,	NULL
1988	NULL
29	NULL
.	NULL

Sambrook	NULL
J	NULL
,	NULL
Fritsch	NULL
EF	NULL
,	NULL
Maniatis	NULL
T	NULL
:	NULL
Molecular	NULL
cloning	NULL
:	NULL
A	NULL
laboratory	NULL
manual	NULL
.	NULL

Cold	NULL
Spring	NULL
Harbor	NULL
,	NULL
NY	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
,	NULL
1989	NULL
30	NULL
.	NULL

Feinberg	NULL
AP	NULL
,	NULL
Vogelstein	NULL
B	NULL
:	NULL
A	NULL
technique	NULL
for	NULL
labeling	NULL
DNA	NULL
restriction	NULL
endonuclease	NULL
fragments	NULL
to	NULL
high	NULL
specific	NULL
activity	NULL
.	NULL

Anal	NULL
Biochem	NULL
132:6	NULL
,	NULL
1983	NULL
31	NULL
.	NULL

Yokota	NULL
T	NULL
,	NULL
Otsuka	NULL
T	NULL
,	NULL
Mosmann	NULL
T	NULL
,	NULL
Banchereau	NULL
J	NULL
,	NULL
DeFrance	NULL
T	NULL
,	NULL
Blanchard	NULL
D	NULL
,	NULL
de	NULL
Vries	NULL
JE	NULL
,	NULL
Lee	NULL
F	NULL
,	NULL
Arai	NULL
KI	NULL
:	NULL
Isolation	NULL
of	NULL
a	NULL
human	NULL
interleukin	NULL
cDNA	NULL
clone	NULL
,	NULL
homologous	NULL
to	NULL
mouse	NULL
B-cell	NULL
stimulatory	NULL
factor	NULL
1	NULL
,	NULL
that	NULL
expresses	NULL
B-cell-	NULL
and	NULL
T-cell-stmulatory	NULL
activities	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
83:5894	NULL
,	NULL
1986	NULL
32	NULL
.	NULL

Fort	NULL
P	NULL
,	NULL
Marty	NULL
L	NULL
,	NULL
Piechaczyk	NULL
M	NULL
,	NULL
el-Sabrouty	NULL
S	NULL
,	NULL
Dani	NULL
C	NULL
,	NULL
Jean-teur	NULL
P	NULL
,	NULL
Blanchard	NULL
JM	NULL
:	NULL
Various	NULL
rat	NULL
adult	NULL
tissues	NULL
express	NULL
only	NULL
one	NULL
major	NULL
mRNA	NULL
species	NULL
from	NULL
the	NULL
glyceraldehyde-3-phosphate-dehy-drogenase	NULL
multigenic	NULL
family	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
13:1431	NULL
,	NULL
1985	NULL
2699	NULL
33	NULL
.	NULL

Park	NULL
J	NULL
,	NULL
Yaseen	NULL
NR	NULL
,	NULL
Hogan	NULL
PG	NULL
,	NULL
Rao	NULL
A	NULL
,	NULL
Sharma	NULL
S	NULL
:	NULL
Phosphory-lation	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
NFATp	NULL
inhibits	NULL
its	NULL
DNA	NULL
binding	NULL
activity	NULL
in	NULL
cyclosporin	NULL
A-treated	NULL
human	NULL
B	NULL
and	NULL
T	NULL
cells	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
270:20653	NULL
,	NULL
1995	NULL
34	NULL
.	NULL

Dignam	NULL
JP	NULL
,	NULL
Lebovitz	NULL
RM	NULL
,	NULL
Roeder	NULL
RG	NULL
:	NULL
Accurate	NULL
transcription	NULL
initiation	NULL
by	NULL
RNA	NULL
polymerase	NULL
II	NULL
in	NULL
a	NULL
soluble	NULL
extract	NULL
from	NULL
isolated	NULL
mammalian	NULL
nuclei	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
11:1475	NULL
,	NULL
1983	NULL
35	NULL
.	NULL

Bradford	NULL
MM	NULL
:	NULL
A	NULL
rapid	NULL
and	NULL
sensitive	NULL
method	NULL
for	NULL
the	NULL
quantita-tion	NULL
of	NULL
microgram	NULL
quantities	NULL
of	NULL
protein	NULL
utilizing	NULL
the	NULL
principle	NULL
of	NULL
protein-dye	NULL
binding	NULL
.	NULL

Anal	NULL
Biochem	NULL
72:248	NULL
,	NULL
1976	NULL
36	NULL
.	NULL

D'Ambrosio	NULL
D	NULL
,	NULL
Trotta	NULL
R	NULL
,	NULL
Vacca	NULL
A	NULL
,	NULL
Frati	NULL
L	NULL
,	NULL
Santoni	NULL
A	NULL
,	NULL
Gul-lino	NULL
A	NULL
,	NULL
Testi	NULL
R	NULL
:	NULL
Transcriptional	NULL
regulation	NULL
of	NULL
interleukin-2	NULL
gene	NULL
expression	NULL
by	NULL
CD69-generated	NULL
signals	NULL
.	NULL

Eur	NULL
J	NULL
Immunol	NULL
23:2993	NULL
,	NULL
1993	NULL
37	NULL
.	NULL

Lai	NULL
J-H	NULL
,	NULL
Horvath	NULL
G	NULL
,	NULL
Subleski	NULL
J	NULL
,	NULL
Bruder	NULL
J	NULL
,	NULL
Ghosh	NULL
P	NULL
,	NULL
Tan	NULL
T-H	NULL
:	NULL
RelA	NULL
is	NULL
a	NULL
potent	NULL
transcriptional	NULL
activator	NULL
of	NULL
the	NULL
CD28	NULL
response	NULL
element	NULL
within	NULL
the	NULL
interleukin	NULL
2	NULL
promoter	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
15:4260	NULL
,	NULL
1995	NULL
38	NULL
.	NULL

Lederer	NULL
JA	NULL
,	NULL
Liou	NULL
JS	NULL
,	NULL
Todd	NULL
MD	NULL
,	NULL
Glimcher	NULL
LH	NULL
,	NULL
Lichtman	NULL
AH	NULL
:	NULL
Regulation	NULL
of	NULL
cytokine	NULL
gene	NULL
expression	NULL
in	NULL
T	NULL
helper	NULL
cell	NULL
subsets	NULL
.	NULL

J	NULL
Immunol	NULL
152:77	NULL
,	NULL
1994	NULL
39	NULL
.	NULL

Verweij	NULL
CL	NULL
,	NULL
Guidos	NULL
C	NULL
,	NULL
Crabtree	NULL
GR	NULL
:	NULL
Cell	NULL
type	NULL
specificity	NULL
and	NULL
activation	NULL
requirements	NULL
for	NULL
NFAT-1	NULL
(	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T-cells	NULL
)	NULL
transcriptional	NULL
activity	NULL
determined	NULL
by	NULL
a	NULL
new	NULL
method	NULL
using	NULL
transgenic	NULL
mice	NULL
to	NULL
assay	NULL
transcriptional	NULL
activity	NULL
of	NULL
an	NULL
individual	NULL
nuclear	NULL
factor	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
265:15788	NULL
,	NULL
1990	NULL
40	NULL
.	NULL

Park	NULL
J-H	NULL
,	NULL
Kaushansky	NULL
K	NULL
,	NULL
Levitt	NULL
L	NULL
:	NULL
Transcriptional	NULL
regulation	NULL
of	NULL
interleukin	NULL
3	NULL
(	NULL
IL3	NULL
)	NULL
in	NULL
primary	NULL
human	NULL
T	NULL
lymphocytes	NULL
Role	NULL
of	NULL
AP-1	NULL
and	NULL
octamer-binding	NULL
proteins	NULL
in	NULL
control	NULL
of	NULL
IL3	NULL
gene	NULL
expression	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
268:6299	NULL
,	NULL
1993	NULL
41	NULL
.	NULL

Flanagan	NULL
WM	NULL
,	NULL
Corthésy	NULL
B	NULL
,	NULL
Bram	NULL
RJ	NULL
,	NULL
Crabtree	NULL
GR	NULL
:	NULL
Nuclear	NULL
association	NULL
of	NULL
a	NULL
T-cell	NULL
transcription	NULL
factor	NULL
blocked	NULL
by	NULL
FK-506	NULL
and	NULL
cyclosporin	NULL
A	NULL
.	NULL

Nature	NULL
352:803	NULL
,	NULL
1991	NULL
42	NULL
.	NULL

Schreiber	NULL
SL	NULL
,	NULL
Crabtree	NULL
GR	NULL
:	NULL
The	NULL
mechanism	NULL
of	NULL
action	NULL
of	NULL
cyclosporin	NULL
A	NULL
and	NULL
FK506	NULL
.	NULL

Immunol	NULL
Today	NULL
13:136	NULL
,	NULL
1992	NULL
43	NULL
.	NULL

Lindsten	NULL
T	NULL
,	NULL
June	NULL
CH	NULL
,	NULL
Ledbetter	NULL
JA	NULL
,	NULL
Stella	NULL
G	NULL
,	NULL
Thompson	NULL
CB	NULL
:	NULL
Regulation	NULL
of	NULL
lymphokine	NULL
messenger	NULL
RNA	NULL
stability	NULL
by	NULL
a	NULL
surface-mediated	NULL
T	NULL
cell	NULL
activation	NULL
pathway	NULL
.	NULL

Science	NULL
244:339	NULL
,	NULL
1989	NULL
44	NULL
.	NULL

Dokter	NULL
WHA	NULL
,	NULL
Sierdsema	NULL
SJ	NULL
,	NULL
Esselink	NULL
MT	NULL
,	NULL
Halie	NULL
MR	NULL
,	NULL
Vellenga	NULL
E	NULL
:	NULL
IL-7	NULL
enhances	NULL
the	NULL
expression	NULL
of	NULL
IL-3	NULL
and	NULL
granulocyte-macrophage-CSF	NULL
mRNA	NULL
in	NULL
activated	NULL
human	NULL
T	NULL
cells	NULL
by	NULL
post-transcriptional	NULL
mechanisms	NULL
.	NULL

J	NULL
Immunol	NULL
150:2584	NULL
,	NULL
1993	NULL
45	NULL
.	NULL

Civil	NULL
A	NULL
,	NULL
Geerts	NULL
M	NULL
,	NULL
Aarden	NULL
LA	NULL
,	NULL
Verweij	NULL
CL	NULL
:	NULL
Evidence	NULL
for	NULL
a	NULL
role	NULL
of	NULL
CD28RE	NULL
as	NULL
a	NULL
response	NULL
element	NULL
for	NULL
distinct	NULL
mitogenic	NULL
T	NULL
cell	NULL
activation	NULL
signals	NULL
.	NULL

Eur	NULL
J	NULL
Immunol	NULL
22:3041	NULL
,	NULL
1992	NULL
46	NULL
.	NULL

Umlauf	NULL
SW	NULL
,	NULL
Beverly	NULL
B	NULL
,	NULL
Lantz	NULL
O	NULL
,	NULL
Schwartz	NULL
RH	NULL
:	NULL
Regulation	NULL
of	NULL
interleukin	NULL
2	NULL
gene	NULL
expression	NULL
by	NULL
CD28	NULL
costimulation	NULL
in	NULL
mouse	NULL
T-cell	NULL
clones	NULL
:	NULL
Both	NULL
nuclear	NULL
and	NULL
cytoplasmic	NULL
RNAs	NULL
are	NULL
regulated	NULL
with	NULL
complex	NULL
kinetics	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
15:3197	NULL
,	NULL
1995	NULL
47	NULL
.	NULL

June	NULL
CH	NULL
,	NULL
Bluestone	NULL
JA	NULL
,	NULL
Nadler	NULL
LM	NULL
,	NULL
Thompson	NULL
CB	NULL
:	NULL
The	NULL
B7	NULL
and	NULL
CD28	NULL
receptor	NULL
families	NULL
.	NULL

Immunol	NULL
Today	NULL
15:321	NULL
,	NULL
1994	NULL
48	NULL
.	NULL

Nunés	NULL
JA	NULL
,	NULL
Truneh	NULL
A	NULL
,	NULL
Olive	NULL
D	NULL
,	NULL
Cantrell	NULL
DA	NULL
:	NULL
Signal	NULL
transduction	NULL
by	NULL
CD28	NULL
costimulatory	NULL
receptor	NULL
on	NULL
T	NULL
cells	NULL
B7-1	NULL
and	NULL
B7-2	NULL
regulation	NULL
of	NULL
tyrosine	NULL
kinase	NULL
adaptor	NULL
molecules	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
271:1591	NULL
,	NULL
1996	NULL
49	NULL
.	NULL

Stein	NULL
PD	NULL
,	NULL
Fraser	NULL
JD	NULL
,	NULL
Weiss	NULL
A	NULL
:	NULL
The	NULL
cytoplasmic	NULL
domain	NULL
of	NULL
CD28	NULL
is	NULL
both	NULL
necessary	NULL
and	NULL
sufficient	NULL
for	NULL
costimulation	NULL
of	NULL
interleukin-2	NULL
secretion	NULL
and	NULL
association	NULL
with	NULL
phosphatidylinositol	NULL
3'-kinase	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
14:3392	NULL
,	NULL
1994	NULL
50	NULL
.	NULL

Jain	NULL
J	NULL
,	NULL
Valge-Archer	NULL
VE	NULL
,	NULL
Rao	NULL
A	NULL
:	NULL
Analysis	NULL
of	NULL
the	NULL
AP-1	NULL
sites	NULL
in	NULL
the	NULL
IL-2	NULL
promoter	NULL
.	NULL

J	NULL
Immunol	NULL
148:1240	NULL
,	NULL
1992	NULL
51	NULL
.	NULL

Foxwell	NULL
BMJ	NULL
,	NULL
Beadling	NULL
C	NULL
,	NULL
Guschin	NULL
D	NULL
,	NULL
Kerr	NULL
I	NULL
,	NULL
Cantrell	NULL
D	NULL
:	NULL
Interleukin-7	NULL
can	NULL
induce	NULL
the	NULL
activation	NULL
of	NULL
Jak	NULL
1	NULL
,	NULL
Jak	NULL
3	NULL
and	NULL
STAT	NULL
5	NULL
proteins	NULL
in	NULL
murine	NULL
T	NULL
cells	NULL
.	NULL

Eur	NULL
J	NULL
Immunol	NULL
25:3041	NULL
,	NULL
1995	NULL
52	NULL
.	NULL

Lin	NULL
J-X	NULL
,	NULL
Migone	NULL
T-S	NULL
,	NULL
Tsang	NULL
M	NULL
,	NULL
Friedmann	NULL
M	NULL
,	NULL
Weatherbee	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

2700	NULL
JA	NULL
,	NULL
Zhou	NULL
L	NULL
,	NULL
Yamauchi	NULL
A	NULL
,	NULL
Bloom	NULL
ET	NULL
,	NULL
Mietz	NULL
J	NULL
,	NULL
John	NULL
S	NULL
,	NULL
Leonard	NULL
WJ	NULL
:	NULL
The	NULL
role	NULL
of	NULL
shared	NULL
receptor	NULL
motifs	NULL
and	NULL
common	NULL
Stat	NULL
proteins	NULL
in	NULL
the	NULL
generation	NULL
of	NULL
cytokine	NULL
pleiotropy	NULL
and	NULL
redundancy	NULL
by	NULL
IL-2	NULL
,	NULL
IL-4	NULL
,	NULL
IL-7	NULL
,	NULL
IL-13	NULL
,	NULL
and	NULL
IL-15	NULL
.	NULL

Immunity	NULL
2:331	NULL
,	NULL
1995	NULL
53	NULL
.	NULL

Page	NULL
TH	NULL
,	NULL
Lali	NULL
FV	NULL
,	NULL
Foxwell	NULL
BMJ	NULL
:	NULL
Interleukin-7	NULL
activates	NULL
p36lck	NULL
and	NULL
p5Qfyn	NULL
,	NULL
two	NULL
tyrosine	NULL
kinases	NULL
associated	NULL
with	NULL
the	NULL
p90	NULL
interleukin-7	NULL
receptor	NULL
in	NULL
primary	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

Eur	NULL
J	NULL
Immunol	NULL
25:2956	NULL
,	NULL
1995	NULL
54	NULL
.	NULL

Sharfe	NULL
N	NULL
,	NULL
Dadi	NULL
HK	NULL
,	NULL
Roifman	NULL
CM	NULL
:	NULL
JAK3	NULL
protein	NULL
tyrosine	NULL
kinase	NULL
mediates	NULL
interleukin-7-induced	NULL
activation	NULL
of	NULL
phosphatidylino-sitol-3	NULL
``	NULL
kinase	NULL
.	NULL

Blood	NULL
86:2077	NULL
,	NULL
1995	NULL
55	NULL
.	NULL

Venkitaraman	NULL
AR	NULL
,	NULL
Cowling	NULL
RJ	NULL
:	NULL
Interleukin	NULL
7	NULL
receptor	NULL
functions	NULL
by	NULL
recruiting	NULL
the	NULL
tyrosine	NULL
kinase	NULL
p5Qfyn	NULL
through	NULL
a	NULL
segment	NULL
of	NULL
its	NULL
cytoplasmic	NULL
tail	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
89:12083	NULL
,	NULL
1992	NULL
56	NULL
.	NULL

Zeng	NULL
Y-X	NULL
,	NULL
Takahashi	NULL
H	NULL
,	NULL
Shibata	NULL
M	NULL
,	NULL
Hirokawa	NULL
K	NULL
:	NULL
JAK3	NULL
Janus	NULL
kinase	NULL
is	NULL
involved	NULL
in	NULL
interleukin	NULL
7	NULL
signal	NULL
pathway	NULL
.	NULL

FEBS	NULL
Lett	NULL
353:289	NULL
,	NULL
1994	NULL
57	NULL
.	NULL

DeSilva	NULL
DR	NULL
,	NULL
Feeser	NULL
WS	NULL
,	NULL
Tancula	NULL
EJ	NULL
,	NULL
Scherle	NULL
PA	NULL
:	NULL
Anergic	NULL
T	NULL
cells	NULL
are	NULL
deficient	NULL
in	NULL
both	NULL
jun	NULL
NH2-terminal	NULL
kinase	NULL
and	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
signaling	NULL
pathways	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
183:2017	NULL
,	NULL
1996	NULL
58	NULL
.	NULL

Genot	NULL
E	NULL
,	NULL
Cleverly	NULL
S	NULL
,	NULL
Henning	NULL
S	NULL
,	NULL
Cantrell	NULL
D	NULL
:	NULL
Multiple	NULL
p21ras	NULL
GRINGHUIS	NULL
ET	NULL
AL	NULL
effector	NULL
pathways	NULL
regulate	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
.	NULL

EMBO	NULL
J	NULL
15:3923	NULL
,	NULL
1996	NULL
59	NULL
.	NULL

Minden	NULL
A	NULL
,	NULL
Lin	NULL
A	NULL
,	NULL
McMahon	NULL
M	NULL
,	NULL
Lange-Carter	NULL
C	NULL
,	NULL
Derijard	NULL
B	NULL
,	NULL
Davis	NULL
RJ	NULL
,	NULL
Johnson	NULL
GL	NULL
,	NULL
Karin	NULL
M	NULL
:	NULL
Differential	NULL
activation	NULL
of	NULL
ERK	NULL
and	NULL
JNK	NULL
mitogen-activated	NULL
protein	NULL
kinases	NULL
by	NULL
Raf-1	NULL
and	NULL
MEKK1	NULL
.	NULL

Science	NULL
266:1719	NULL
,	NULL
1994	NULL
60	NULL
.	NULL

Angel	NULL
P	NULL
,	NULL
Karin	NULL
M	NULL
:	NULL
The	NULL
role	NULL
of	NULL
Jun	NULL
,	NULL
Fos	NULL
and	NULL
the	NULL
AP-1	NULL
complex	NULL
in	NULL
cell-proliferation	NULL
and	NULL
transformation	NULL
.	NULL

Biochim	NULL
Biophys	NULL
Acta	NULL
1072:129	NULL
,	NULL
1991	NULL
61	NULL
.	NULL

Hibi	NULL
M	NULL
,	NULL
Lin	NULL
A	NULL
,	NULL
Smeal	NULL
T	NULL
,	NULL
Minden	NULL
A	NULL
,	NULL
Karin	NULL
M	NULL
:	NULL
Identification	NULL
of	NULL
an	NULL
oncoprotein-	NULL
and	NULL
UV-responsive	NULL
protein	NULL
kinase	NULL
that	NULL
binds	NULL
and	NULL
potentiates	NULL
the	NULL
c-Jun	NULL
activation	NULL
domain	NULL
.	NULL

Genes	NULL
Dev	NULL
7:2135	NULL
,	NULL
1993	NULL
62	NULL
.	NULL

Li	NULL
S	NULL
,	NULL
Sedivy	NULL
J	NULL
:	NULL
Raf-1	NULL
protein	NULL
kinase	NULL
activates	NULL
the	NULL
NF-KB	NULL
transcription	NULL
factor	NULL
by	NULL
dissociating	NULL
the	NULL
cytoplasmic	NULL
NF-kB-I	NULL
«	NULL
B	NULL
complex	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
90:9247	NULL
,	NULL
1993	NULL
63	NULL
.	NULL

Su	NULL
B	NULL
,	NULL
Jacinto	NULL
E	NULL
,	NULL
Hibi	NULL
M	NULL
,	NULL
Kallunki	NULL
T	NULL
,	NULL
Karin	NULL
M	NULL
,	NULL
Ben-Neriah	NULL
Y	NULL
:	NULL
JNK	NULL
is	NULL
involved	NULL
in	NULL
signal	NULL
integration	NULL
during	NULL
costimulation	NULL
of	NULL
T	NULL
lymphocytes	NULL
.	NULL

Cell	NULL
77:727	NULL
,	NULL
1994	NULL
64	NULL
.	NULL

Mui	NULL
AL-F	NULL
,	NULL
Wakao	NULL
H	NULL
,	NULL
Kinoshita	NULL
T	NULL
,	NULL
Kitamura	NULL
T	NULL
,	NULL
Miyajima	NULL
A	NULL
:	NULL
Suppression	NULL
of	NULL
interleukin-3-induced	NULL
gene	NULL
expression	NULL
by	NULL
a	NULL
C-termi-nal	NULL
truncated	NULL
Stat5	NULL
:	NULL
Role	NULL
of	NULL
Stat5	NULL
in	NULL
proliferation	NULL
.	NULL

EMBO	NULL
J	NULL
15:2425	NULL
,	NULL
1996	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

®	NULL
blO	NULL
0d	NULL
1997	NULL
90	NULL
:	NULL
2690-2700	NULL
Interleukin-7	NULL
Upregulates	NULL
the	NULL
Interleukin-2-Gene	NULL
Expression	NULL
in	NULL
Activated	NULL
Human	NULL
T	NULL
Lymphocytes	NULL
at	NULL
the	NULL
Transcriptional	NULL
Level	NULL
by	NULL
Enhancing	NULL
the	NULL
DNA	NULL
Binding	NULL
Activities	NULL
of	NULL
Both	NULL
Nuclear	NULL
Factor	NULL
of	NULL
Activated	NULL
T	NULL
Cells	NULL
and	NULL
Activator	NULL
Protein-1	NULL
A	NULL
_	NULL
48	NULL
o	NULL
6	NULL
'	NULL
t	NULL
\se	NULL
@	NULL
.	NULL

/	NULL
{	NULL
®	NULL
Sonja	NULL
|	NULL
.	NULL

Gringhuis	NULL
,	NULL
Lou	NULL
F.M.H	NULL
.	NULL

de	NULL
Leij	NULL
,	NULL
Emmy	NULL
W.	NULL
Verschuren	NULL
,	NULL
Peter	NULL
Borger	NULL
and	NULL
Edo	NULL
Vellenga	NULL
Updated	NULL
information	NULL
and	NULL
services	NULL
can	NULL
be	NULL
found	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/content/90/7/2690.full.html	NULL
Articles	NULL
on	NULL
similar	NULL
topics	NULL
can	NULL
be	NULL
found	NULL
in	NULL
the	NULL
following	NULL
Blood	NULL
collections	NULL
Immunobiology	NULL
and	NULL
Immunotherapy	NULL
(	NULL
5679	NULL
articles	NULL
)	NULL
Information	NULL
about	NULL
reproducing	NULL
this	NULL
article	NULL
in	NULL
parts	NULL
or	NULL
in	NULL
its	NULL
entirety	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
requests	NULL
Information	NULL
about	NULL
ordering	NULL
reprints	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/misc/rights.xhtml	NULL
#	NULL
reprints	NULL
Information	NULL
about	NULL
subscriptions	NULL
and	NULL
ASH	NULL
membership	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/subscriptions/index.xhtml	NULL
Blood	NULL
(	NULL
print	NULL
ISSN	NULL
0006-4971	NULL
,	NULL
online	NULL
ISSN	NULL
1528-0020	NULL
)	NULL
,	NULL
is	NULL
published	NULL
weekly	NULL
by	NULL
the	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
,	NULL
2021	NULL
L	NULL
St	NULL
,	NULL
NW	NULL
,	NULL
Suite	NULL
900	NULL
,	NULL
Washington	NULL
DC	NULL
20036	NULL
.	NULL

Copyright	NULL
2011	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
;	NULL
all	NULL
rights	NULL
reserved	NULL
.	NULL

